{
    "abstract": "Background: A more affordable pneumococcal conjugate vaccine (PCV) that provides comparable protection to current PCVs is needed to ensure sustainable access in resource-limited settings. Serum Institute of India Pvt. Ltd.\u2019s PCV candidate (SIIPL-PCV) has the potential to meet this need as manufacturing efficiency has been optimized and the vaccine targets the most prevalent disease-causing serotypes in Africa and Asia. We report SIIPL-PCV's safety, tolerability, and immunogenicity in adults, toddlers, and infants in The Gambia. Methods: This phase 1/2, randomized, double-blind trial sequentially enrolled 34 PCV-naive adults (18\u201340 years old), 112 PCV (Prevenar 13\u00ae [PCV13])-primed toddlers (12\u201315 months old), and 200 PCV-naive infants (6\u20138 weeks old), who were randomized (1:1) to receive SIIPL-PCV or a licensed comparator vaccine. Infants received three-doses of SIIPL-PCV or PCV13 at 6, 10, and 14 weeks of age co-administered with routine Expanded Program on Immunization (EPI) vaccines. Reactogenicity was solicited through seven-days post-vaccination; unsolicited adverse events (AEs) were assessed throughout the study. The safety and immunogenicity of a matching booster at 10\u201314 months of age were evaluated in a subset of 96 infants. Immune responses were evaluated post-primary and pre- and post-booster vaccinations. Results: Reactogenicity was primarily mild-to-moderate in severity. In infants, the most common solicited reactions were injection-site tenderness and fever, with no meaningful treatment-group differences. There were no serious or severe vaccine-related AEs and no meaningful trends in SAEs, vaccine-related AEs, or overall AEs. Infant post-primary seroresponse rates (IgG level \u2265 0.35 \u00b5g/mL) were \u226589% for all serotypes except 6A (79%) in the SIIPL-PCV group. IgG GMCs were >1 \u00b5g/mL for all serotypes in both SIIPL-PCV and PCV13 groups. Post-booster GMCs were comparable between groups. Conclusion: SIIPL-PCV was well-tolerated, had an acceptable safety profile, and was immunogenic for all vaccine serotypes. Results support the evaluation of SIIPL-PCV in a phase 3 non-inferiority trial. Clinicaltrials.gov: NCT02308540.",
    "author_highlights": [
        {
            "endOffset": 20302,
            "sentence": "Safe, effective and more affordable pneumococcal conjugate vaccines (PCV) are needed.",
            "startOffset": 20217
        },
        {
            "endOffset": 20399,
            "sentence": "This new PCV targets serotypes most likely to cause disease in low- and middle-income countries.",
            "startOffset": 20303
        },
        {
            "endOffset": 20493,
            "sentence": "The vaccine was safe and immunogenic in adults, toddlers and infants in this phase 1/2 trial.",
            "startOffset": 20400
        },
        {
            "endOffset": 20567,
            "sentence": "The data support progression to a phase 3 licensure trial of the new PCV.",
            "startOffset": 20494
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Liu"
                },
                {
                    "first": "Shefali",
                    "initial": "S.",
                    "last": "Oza"
                },
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Hogan"
                },
                {
                    "first": "Yue",
                    "initial": "Y.",
                    "last": "Chu"
                },
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Perin"
                },
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Zhu"
                },
                {
                    "first": "Joy E.",
                    "initial": "J.E.",
                    "last": "Lawn"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Cousens"
                },
                {
                    "first": "Colin",
                    "initial": "C.",
                    "last": "Mathers"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Black"
                }
            ],
            "doi": "10.1016/S0140-6736(16)31593-8",
            "firstpage": "3027",
            "issn": "01406736",
            "lastpage": "3035",
            "pmid": "27839855",
            "pub_year": 2016,
            "title": "Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the Sustainable Development Goals",
            "volume": "388"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Joseph Raymond",
                    "initial": "J.R.",
                    "last": "Zunt"
                },
                {
                    "first": "Nicholas J.",
                    "initial": "N.J.",
                    "last": "Kassebaum"
                },
                {
                    "first": "Natacha",
                    "initial": "N.",
                    "last": "Blake"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Glennie"
                },
                {
                    "first": "Claire",
                    "initial": "C.",
                    "last": "Wright"
                },
                {
                    "first": "Emma",
                    "initial": "E.",
                    "last": "Nichols"
                },
                {
                    "first": "Foad",
                    "initial": "F.",
                    "last": "Abd-Allah"
                },
                {
                    "first": "Jemal",
                    "initial": "J.",
                    "last": "Abdela"
                },
                {
                    "first": "Ahmed",
                    "initial": "A.",
                    "last": "Abdelalim"
                },
                {
                    "first": "Abdu A.",
                    "initial": "A.A.",
                    "last": "Adamu"
                },
                {
                    "first": "Mina G.",
                    "initial": "M.G.",
                    "last": "Adib"
                },
                {
                    "first": "Alireza",
                    "initial": "A.",
                    "last": "Ahmadi"
                },
                {
                    "first": "Muktar Beshir",
                    "initial": "M.B.",
                    "last": "Ahmed"
                },
                {
                    "first": "Amani Nidhal",
                    "initial": "A.N.",
                    "last": "Aichour"
                },
                {
                    "first": "Ibtihel",
                    "initial": "I.",
                    "last": "Aichour"
                },
                {
                    "first": "Miloud Taki Eddine",
                    "initial": "M.T.E.",
                    "last": "Aichour"
                },
                {
                    "first": "Nadia",
                    "initial": "N.",
                    "last": "Akseer"
                },
                {
                    "first": "Rajaa M.",
                    "initial": "R.M.",
                    "last": "Al-Raddadi"
                },
                {
                    "first": "Fares",
                    "initial": "F.",
                    "last": "Alahdab"
                },
                {
                    "first": "Kefyalew Addis",
                    "initial": "K.A.",
                    "last": "Alene"
                },
                {
                    "first": "Syed Mohamed",
                    "initial": "S.M.",
                    "last": "Aljunid"
                },
                {
                    "first": "Mohammad A.",
                    "initial": "M.A.",
                    "last": "AlMazroa"
                },
                {
                    "first": "Khalid",
                    "initial": "K.",
                    "last": "Altirkawi"
                },
                {
                    "first": "Nelson",
                    "initial": "N.",
                    "last": "Alvis-Guzman"
                },
                {
                    "first": "Megbaru Debalkie",
                    "initial": "M.D.",
                    "last": "Animut"
                },
                {
                    "first": "Mina",
                    "initial": "M.",
                    "last": "Anjomshoa"
                },
                {
                    "first": "Mustafa Geleto",
                    "initial": "M.G.",
                    "last": "Ansha"
                },
                {
                    "first": "Rana Jawad",
                    "initial": "R.J.",
                    "last": "Asghar"
                },
                {
                    "first": "Euripide F.G.A.",
                    "initial": "E.F.G.A.",
                    "last": "Avokpaho"
                },
                {
                    "first": "Ashish",
                    "initial": "A.",
                    "last": "Awasthi"
                },
                {
                    "first": "Hamid",
                    "initial": "H.",
                    "last": "Badali"
                },
                {
                    "first": "Aleksandra",
                    "initial": "A.",
                    "last": "Barac"
                },
                {
                    "first": "Till Winfried",
                    "initial": "T.W.",
                    "last": "B\u00e4rnighausen"
                },
                {
                    "first": "Quique",
                    "initial": "Q.",
                    "last": "Bassat"
                },
                {
                    "first": "Neeraj",
                    "initial": "N.",
                    "last": "Bedi"
                },
                {
                    "first": "Abate Bekele",
                    "initial": "A.B.",
                    "last": "Belachew"
                },
                {
                    "first": "Krittika",
                    "initial": "K.",
                    "last": "Bhattacharyya"
                },
                {
                    "first": "Zulfiqar A.",
                    "initial": "Z.A.",
                    "last": "Bhutta"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Bijani"
                },
                {
                    "first": "Zahid A.",
                    "initial": "Z.A.",
                    "last": "Butt"
                },
                {
                    "first": "F\u00e9lix",
                    "initial": "F.",
                    "last": "Carvalho"
                },
                {
                    "first": "Carlos A.",
                    "initial": "C.A.",
                    "last": "Casta\u00f1eda-Orjuela"
                },
                {
                    "first": "Abdulaal",
                    "initial": "A.",
                    "last": "Chitheer"
                },
                {
                    "first": "Jee Young J.",
                    "initial": "J.Y.J.",
                    "last": "Choi"
                },
                {
                    "first": "Devasahayam J.",
                    "initial": "D.J.",
                    "last": "Christopher"
                },
                {
                    "first": "Anh Kim",
                    "initial": "A.K.",
                    "last": "Dang"
                },
                {
                    "first": "Ahmad",
                    "initial": "A.",
                    "last": "Daryani"
                },
                {
                    "first": "Gebre Teklemariam",
                    "initial": "G.T.",
                    "last": "Demoz"
                },
                {
                    "first": "Shirin",
                    "initial": "S.",
                    "last": "Djalalinia"
                },
                {
                    "first": "Huyen Phuc",
                    "initial": "H.P.",
                    "last": "Do"
                },
                {
                    "first": "Manisha",
                    "initial": "M.",
                    "last": "Dubey"
                },
                {
                    "first": "Eleonora",
                    "initial": "E.",
                    "last": "Dubljanin"
                },
                {
                    "first": "Eyasu Ejeta",
                    "initial": "E.E.",
                    "last": "Duken"
                },
                {
                    "first": "Maysaa",
                    "initial": "M.",
                    "last": "El Sayed Zaki"
                },
                {
                    "first": "Iqbal RF",
                    "initial": "I.R.",
                    "last": "Elyazar"
                },
                {
                    "first": "Hamed",
                    "initial": "H.",
                    "last": "Fakhim"
                },
                {
                    "first": "Eduarda",
                    "initial": "E.",
                    "last": "Fernandes"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Fischer"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Fukumoto"
                },
                {
                    "first": "Morsaleh",
                    "initial": "M.",
                    "last": "Ganji"
                },
                {
                    "first": "Abadi Kahsu",
                    "initial": "A.K.",
                    "last": "Gebre"
                },
                {
                    "first": "Afewerki",
                    "initial": "A.",
                    "last": "Gebremeskel"
                },
                {
                    "first": "Bradford D.",
                    "initial": "B.D.",
                    "last": "Gessner"
                },
                {
                    "first": "Sameer Vali",
                    "initial": "S.V.",
                    "last": "Gopalani"
                },
                {
                    "first": "Yuming",
                    "initial": "Y.",
                    "last": "Guo"
                },
                {
                    "first": "Rahul",
                    "initial": "R.",
                    "last": "Gupta"
                },
                {
                    "first": "Gessessew Bugssa",
                    "initial": "G.B.",
                    "last": "Hailu"
                },
                {
                    "first": "Arvin",
                    "initial": "A.",
                    "last": "Haj-Mirzaian"
                },
                {
                    "first": "Samer",
                    "initial": "S.",
                    "last": "Hamidi"
                },
                {
                    "first": "Simon I.",
                    "initial": "S.I.",
                    "last": "Hay"
                },
                {
                    "first": "Andualem",
                    "initial": "A.",
                    "last": "Henok"
                },
                {
                    "first": "Seyed Sina Naghibi",
                    "initial": "S.S.N.",
                    "last": "Irvani"
                },
                {
                    "first": "Ravi Prakash",
                    "initial": "R.P.",
                    "last": "Jha"
                },
                {
                    "first": "Mikk",
                    "initial": "M.",
                    "last": "J\u00dcRISSON"
                },
                {
                    "first": "Amaha",
                    "initial": "A.",
                    "last": "Kahsay"
                },
                {
                    "first": "Manoochehr",
                    "initial": "M.",
                    "last": "Karami"
                },
                {
                    "first": "Andr\u00e9",
                    "initial": "A.",
                    "last": "Karch"
                },
                {
                    "first": "Amir",
                    "initial": "A.",
                    "last": "Kasaeian"
                },
                {
                    "first": "Getachew Mullu",
                    "initial": "G.M.",
                    "last": "Kassa"
                },
                {
                    "first": "Tesfaye Dessale Dessale",
                    "initial": "T.D.D.",
                    "last": "Kassa"
                },
                {
                    "first": "Adane Teshome",
                    "initial": "A.T.",
                    "last": "Kefale"
                },
                {
                    "first": "Yousef Saleh",
                    "initial": "Y.S.",
                    "last": "Khader"
                },
                {
                    "first": "Ibrahim A.",
                    "initial": "I.A.",
                    "last": "Khalil"
                },
                {
                    "first": "Ejaz Ahmad",
                    "initial": "E.A.",
                    "last": "Khan"
                },
                {
                    "first": "Young Ho",
                    "initial": "Y.H.",
                    "last": "Khang"
                },
                {
                    "first": "Jagdish",
                    "initial": "J.",
                    "last": "Khubchandani"
                },
                {
                    "first": "Ruth W.",
                    "initial": "R.W.",
                    "last": "Kimokoti"
                },
                {
                    "first": "Adnan",
                    "initial": "A.",
                    "last": "Kisa"
                },
                {
                    "first": "Faris Hasan",
                    "initial": "F.H.",
                    "last": "Lami"
                },
                {
                    "first": "Miriam",
                    "initial": "M.",
                    "last": "Levi"
                },
                {
                    "first": "Shanshan",
                    "initial": "S.",
                    "last": "Li"
                },
                {
                    "first": "Clement T.",
                    "initial": "C.T.",
                    "last": "Loy"
                },
                {
                    "first": "Marek",
                    "initial": "M.",
                    "last": "Majdan"
                },
                {
                    "first": "Azeem",
                    "initial": "A.",
                    "last": "Majeed"
                },
                {
                    "first": "Lorenzo Giovanni",
                    "initial": "L.G.",
                    "last": "Mantovani"
                },
                {
                    "first": "Francisco Rogerl\u00e2ndio",
                    "initial": "F.R.",
                    "last": "Martins-Melo"
                },
                {
                    "first": "Colm",
                    "initial": "C.",
                    "last": "Mcalinden"
                },
                {
                    "first": "Varshil",
                    "initial": "V.",
                    "last": "Mehta"
                },
                {
                    "first": "Addisu",
                    "initial": "A.",
                    "last": "Melese"
                },
                {
                    "first": "Ziad A.",
                    "initial": "Z.A.",
                    "last": "Memish"
                },
                {
                    "first": "Desalegn Tadese",
                    "initial": "D.T.",
                    "last": "Mengistu"
                },
                {
                    "first": "Getnet",
                    "initial": "G.",
                    "last": "Mengistu"
                },
                {
                    "first": "Tomislav",
                    "initial": "T.",
                    "last": "Mestrovic"
                },
                {
                    "first": "Haftay Berhane",
                    "initial": "H.B.",
                    "last": "Mezgebe"
                },
                {
                    "first": "Bartosz",
                    "initial": "B.",
                    "last": "Miazgowski"
                },
                {
                    "first": "Branko",
                    "initial": "B.",
                    "last": "Milosevic"
                },
                {
                    "first": "Ali H.",
                    "initial": "A.H.",
                    "last": "Mokdad"
                },
                {
                    "first": "Lorenzo",
                    "initial": "L.",
                    "last": "Monasta"
                },
                {
                    "first": "Ghobad",
                    "initial": "G.",
                    "last": "Moradi"
                },
                {
                    "first": "Paula",
                    "initial": "P.",
                    "last": "Moraga"
                },
                {
                    "first": "Seyyed Meysam",
                    "initial": "S.M.",
                    "last": "Mousavi"
                },
                {
                    "first": "Ulrich Otto",
                    "initial": "U.O.",
                    "last": "Mueller"
                },
                {
                    "first": "Srinivas",
                    "initial": "S.",
                    "last": "Murthy"
                },
                {
                    "first": "Ghulam",
                    "initial": "G.",
                    "last": "Mustafa"
                },
                {
                    "first": "Aliya",
                    "initial": "A.",
                    "last": "Naheed"
                },
                {
                    "first": "Gurudatta",
                    "initial": "G.",
                    "last": "Naik"
                },
                {
                    "first": "Charles Richard James",
                    "initial": "C.R.J.",
                    "last": "Newton"
                },
                {
                    "first": "Yirga Legesse",
                    "initial": "Y.L.",
                    "last": "Nirayo"
                },
                {
                    "first": "Molly R.",
                    "initial": "M.R.",
                    "last": "Nixon"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Ofori-Asenso"
                },
                {
                    "first": "Felix Akpojene",
                    "initial": "F.A.",
                    "last": "Ogbo"
                },
                {
                    "first": "Andrew T.",
                    "initial": "A.T.",
                    "last": "Olagunju"
                },
                {
                    "first": "Tinuke O.",
                    "initial": "T.O.",
                    "last": "Olagunju"
                },
                {
                    "first": "Bolajoko Olubukunola",
                    "initial": "B.O.",
                    "last": "Olusanya"
                },
                {
                    "first": "Justin R.",
                    "initial": "J.R.",
                    "last": "Ortiz"
                },
                {
                    "first": "Mayowa Ojo",
                    "initial": "M.O.",
                    "last": "Owolabi"
                },
                {
                    "first": "Shanti",
                    "initial": "S.",
                    "last": "Patel"
                },
                {
                    "first": "Gabriel D.",
                    "initial": "G.D.",
                    "last": "Pinilla-Monsalve"
                },
                {
                    "first": "Maarten J.",
                    "initial": "M.J.",
                    "last": "Postma"
                },
                {
                    "first": "Mostafa",
                    "initial": "M.",
                    "last": "Qorbani"
                },
                {
                    "first": "Alireza",
                    "initial": "A.",
                    "last": "Rafiei"
                },
                {
                    "first": "Vafa",
                    "initial": "V.",
                    "last": "Rahimi-Movaghar"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Reiner"
                },
                {
                    "first": "Andre M.N.",
                    "initial": "A.M.N.",
                    "last": "Renzaho"
                },
                {
                    "first": "Mohammad Sadegh",
                    "initial": "M.S.",
                    "last": "Rezai"
                },
                {
                    "first": "Kedir Teji",
                    "initial": "K.T.",
                    "last": "Roba"
                },
                {
                    "first": "Luca",
                    "initial": "L.",
                    "last": "Ronfani"
                },
                {
                    "first": "Gholamreza",
                    "initial": "G.",
                    "last": "Roshandel"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Rostami"
                },
                {
                    "first": "Hosein",
                    "initial": "H.",
                    "last": "Safari"
                },
                {
                    "first": "Saeed",
                    "initial": "S.",
                    "last": "Safari"
                },
                {
                    "first": "Saeid",
                    "initial": "S.",
                    "last": "Safiri"
                },
                {
                    "first": "Rajesh",
                    "initial": "R.",
                    "last": "Sagar"
                },
                {
                    "first": "Abdallah M.",
                    "initial": "A.M.",
                    "last": "Samy"
                },
                {
                    "first": "Milena M.",
                    "initial": "M.M.",
                    "last": "Santric Milicevic"
                },
                {
                    "first": "Benn",
                    "initial": "B.",
                    "last": "Sartorius"
                },
                {
                    "first": "Shahabeddin",
                    "initial": "S.",
                    "last": "Sarvi"
                },
                {
                    "first": "Monika",
                    "initial": "M.",
                    "last": "Sawhney"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Saxena"
                },
                {
                    "first": "Azadeh",
                    "initial": "A.",
                    "last": "Shafieesabet"
                },
                {
                    "first": "Masood Ali",
                    "initial": "M.A.",
                    "last": "Shaikh"
                },
                {
                    "first": "Mehdi",
                    "initial": "M.",
                    "last": "Sharif"
                },
                {
                    "first": "Mika",
                    "initial": "M.",
                    "last": "Shigematsu"
                },
                {
                    "first": "Si",
                    "initial": "S.",
                    "last": "Si"
                },
                {
                    "first": "Eirini",
                    "initial": "E.",
                    "last": "Skiadaresi"
                },
                {
                    "first": "Mari",
                    "initial": "M.",
                    "last": "Smith"
                },
                {
                    "first": "Ranjani",
                    "initial": "R.",
                    "last": "Somayaji"
                },
                {
                    "first": "Mu'awiyyah Babale",
                    "initial": "M.B.",
                    "last": "Sufiyan"
                },
                {
                    "first": "Nega Yimer",
                    "initial": "N.Y.",
                    "last": "Tawye"
                },
                {
                    "first": "Mohamad Hani",
                    "initial": "M.H.",
                    "last": "Temsah"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "Tortajada-Girb\u00e9s"
                },
                {
                    "first": "Bach Xuan",
                    "initial": "B.X.",
                    "last": "Tran"
                },
                {
                    "first": "Khanh Bao",
                    "initial": "K.B.",
                    "last": "Tran"
                },
                {
                    "first": "Kingsley Nnanna",
                    "initial": "K.N.",
                    "last": "Ukwaja"
                },
                {
                    "first": "Irfan",
                    "initial": "I.",
                    "last": "Ullah"
                },
                {
                    "first": "Isidora S.",
                    "initial": "I.S.",
                    "last": "Vujcic"
                },
                {
                    "first": "Fasil Shiferaw",
                    "initial": "F.S.",
                    "last": "Wagnew"
                },
                {
                    "first": "Yasir",
                    "initial": "Y.",
                    "last": "Waheed"
                },
                {
                    "first": "Kidu Gidey",
                    "initial": "K.G.",
                    "last": "Weldegwergs"
                },
                {
                    "first": "Andrea Sylvia",
                    "initial": "A.S.",
                    "last": "Winkler"
                },
                {
                    "first": "Charles Shey",
                    "initial": "C.S.",
                    "last": "Wiysonge"
                },
                {
                    "first": "Alison B.",
                    "initial": "A.B.",
                    "last": "Wiyeh"
                },
                {
                    "first": "Grant M.A.",
                    "initial": "G.M.A.",
                    "last": "Wyper"
                },
                {
                    "first": "Ebrahim M.",
                    "initial": "E.M.",
                    "last": "Yimer"
                },
                {
                    "first": "Naohiro",
                    "initial": "N.",
                    "last": "Yonemoto"
                },
                {
                    "first": "Zoubida",
                    "initial": "Z.",
                    "last": "Zaidi"
                },
                {
                    "first": "Zerihun Menlkalew",
                    "initial": "Z.M.",
                    "last": "Zenebe"
                },
                {
                    "first": "Valery L.",
                    "initial": "V.L.",
                    "last": "Feigin"
                },
                {
                    "first": "Theo",
                    "initial": "T.",
                    "last": "Vos"
                },
                {
                    "first": "Christopher J.L.",
                    "initial": "C.J.L.",
                    "last": "Murray"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/S1474-4422(18)30387-9",
            "firstpage": "1061",
            "issn": "14744422",
            "lastpage": "1082",
            "pmid": "30507391",
            "pub_year": 2018,
            "title": "Global, regional, and national burden of meningitis, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016",
            "volume": "17"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Wahl"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Adena",
                    "initial": "A.",
                    "last": "Greenbaum"
                },
                {
                    "first": "Anwesha",
                    "initial": "A.",
                    "last": "Majumder"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Liu"
                },
                {
                    "first": "Yue",
                    "initial": "Y.",
                    "last": "Chu"
                },
                {
                    "first": "Ivana",
                    "initial": "I.",
                    "last": "Luk\u0161i\u0107"
                },
                {
                    "first": "Harish",
                    "initial": "H.",
                    "last": "Nair"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "McAllister"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Rudan"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Black"
                },
                {
                    "first": "Maria Deloria",
                    "initial": "M.D.",
                    "last": "Knoll"
                }
            ],
            "doi": "10.1016/S2214-109X(18)30247-X",
            "firstpage": "e744",
            "issn": "2214109X",
            "lastpage": "e757",
            "pmid": "29903376",
            "pub_year": 2018,
            "title": "Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315",
            "volume": "6"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Stanley",
                    "initial": "S.",
                    "last": "Plotkin"
                },
                {
                    "first": "Peter R.",
                    "initial": "P.R.",
                    "last": "Paradiso"
                }
            ],
            "doi": "10.1093/cid/cir142",
            "firstpage": "1241",
            "issn": "10584838",
            "lastpage": "1247",
            "pmid": "21507921",
            "pub_year": 2011,
            "title": "Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children",
            "volume": "52"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Cynthia G.",
                    "initial": "C.G.",
                    "last": "Whitney"
                },
                {
                    "first": "Monica M.",
                    "initial": "M.M.",
                    "last": "Farley"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Hadler"
                },
                {
                    "first": "Lee H.",
                    "initial": "L.H.",
                    "last": "Harrison"
                },
                {
                    "first": "Nancy M.",
                    "initial": "N.M.",
                    "last": "Bennett"
                },
                {
                    "first": "Ruth",
                    "initial": "R.",
                    "last": "Lynfield"
                },
                {
                    "first": "Arthur",
                    "initial": "A.",
                    "last": "Reingold"
                },
                {
                    "first": "Paul R.",
                    "initial": "P.R.",
                    "last": "Cieslak"
                },
                {
                    "first": "Tamara",
                    "initial": "T.",
                    "last": "Pilishvili"
                },
                {
                    "first": "Delois",
                    "initial": "D.",
                    "last": "Jackson"
                },
                {
                    "first": "Richard R.",
                    "initial": "R.R.",
                    "last": "Facklam"
                },
                {
                    "first": "James H.",
                    "initial": "J.H.",
                    "last": "Jorgensen"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Schuchat"
                }
            ],
            "doi": "10.1056/NEJMoa022823",
            "firstpage": "1737",
            "issn": "00284793",
            "lastpage": "1746",
            "pmid": "12724479",
            "pub_year": 2003,
            "title": "Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine",
            "volume": "348"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Tamara",
                    "initial": "T.",
                    "last": "Pilishvili"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Lexau"
                },
                {
                    "first": "Monica M.",
                    "initial": "M.M.",
                    "last": "Farley"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Hadler"
                },
                {
                    "first": "Lee H.",
                    "initial": "L.H.",
                    "last": "Harrison"
                },
                {
                    "first": "Nancy M.",
                    "initial": "N.M.",
                    "last": "Bennett"
                },
                {
                    "first": "Arthur",
                    "initial": "A.",
                    "last": "Reingold"
                },
                {
                    "first": "Ann",
                    "initial": "A.",
                    "last": "Thomas"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Schaffner"
                },
                {
                    "first": "Allen S.",
                    "initial": "A.S.",
                    "last": "Craig"
                },
                {
                    "first": "Philip J.",
                    "initial": "P.J.",
                    "last": "Smith"
                },
                {
                    "first": "Bernard W.",
                    "initial": "B.W.",
                    "last": "Beall"
                },
                {
                    "first": "Cynthia G.",
                    "initial": "C.G.",
                    "last": "Whitney"
                },
                {
                    "first": "Matthew R.",
                    "initial": "M.R.",
                    "last": "Moore"
                }
            ],
            "doi": "10.1086/648593",
            "firstpage": "32",
            "issn": "00221899",
            "lastpage": "41",
            "pmid": "19947881",
            "pub_year": 2010,
            "title": "Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine",
            "volume": "201"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Grant A.",
                    "initial": "G.A.",
                    "last": "Mackenzie"
                },
                {
                    "first": "Philip C.",
                    "initial": "P.C.",
                    "last": "Hill"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Jeffries"
                },
                {
                    "first": "Ilias",
                    "initial": "I.",
                    "last": "Hossain"
                },
                {
                    "first": "Uchendu",
                    "initial": "U.",
                    "last": "Uchendu"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Ameh"
                },
                {
                    "first": "Malick",
                    "initial": "M.",
                    "last": "Ndiaye"
                },
                {
                    "first": "Oyedeji",
                    "initial": "O.",
                    "last": "Adeyemi"
                },
                {
                    "first": "Jayani",
                    "initial": "J.",
                    "last": "Pathirana"
                },
                {
                    "first": "Yekini",
                    "initial": "Y.",
                    "last": "Olatunji"
                },
                {
                    "first": "Bade",
                    "initial": "B.",
                    "last": "Abatan"
                },
                {
                    "first": "Bilquees S.",
                    "initial": "B.S.",
                    "last": "Muhammad"
                },
                {
                    "first": "Augustin E.",
                    "initial": "A.E.",
                    "last": "Fombah"
                },
                {
                    "first": "Debasish",
                    "initial": "D.",
                    "last": "Saha"
                },
                {
                    "first": "Ian",
                    "initial": "I.",
                    "last": "Plumb"
                },
                {
                    "first": "Aliu",
                    "initial": "A.",
                    "last": "Akano"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Ebruke"
                },
                {
                    "first": "Readon C.",
                    "initial": "R.C.",
                    "last": "Ideh"
                },
                {
                    "first": "Bankole",
                    "initial": "B.",
                    "last": "Kuti"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Githua"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Olutunde"
                },
                {
                    "first": "Ogochukwu",
                    "initial": "O.",
                    "last": "Ofordile"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Green"
                },
                {
                    "first": "Effua",
                    "initial": "E.",
                    "last": "Usuf"
                },
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Badji"
                },
                {
                    "first": "Usman N.A.",
                    "initial": "U.N.A.",
                    "last": "Ikumapayi"
                },
                {
                    "first": "Ahmad",
                    "initial": "A.",
                    "last": "Manjang"
                },
                {
                    "first": "Rasheed",
                    "initial": "R.",
                    "last": "Salaudeen"
                },
                {
                    "first": "E. David",
                    "initial": "E.D.",
                    "last": "Nsekpong"
                },
                {
                    "first": "Sheikh",
                    "initial": "S.",
                    "last": "Jarju"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Antonio"
                },
                {
                    "first": "Sana",
                    "initial": "S.",
                    "last": "Sambou"
                },
                {
                    "first": "Lamin",
                    "initial": "L.",
                    "last": "Ceesay"
                },
                {
                    "first": "Yamundow",
                    "initial": "Y.",
                    "last": "Lowe-Jallow"
                },
                {
                    "first": "Momodou",
                    "initial": "M.",
                    "last": "Jasseh"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Mulholland"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Knoll"
                },
                {
                    "first": "Orin S.",
                    "initial": "O.S.",
                    "last": "Levine"
                },
                {
                    "first": "Stephen R.",
                    "initial": "S.R.",
                    "last": "Howie"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Adegbola"
                },
                {
                    "first": "Brian M.",
                    "initial": "B.M.",
                    "last": "Greenwood"
                },
                {
                    "first": "Tumani",
                    "initial": "T.",
                    "last": "Corrah"
                }
            ],
            "doi": "10.1016/S1473-3099(16)00054-2",
            "firstpage": "703",
            "issn": "14733099",
            "lastpage": "711",
            "pmid": "26897105",
            "pub_year": 2016,
            "title": "Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study",
            "volume": "16"
        },
        "b0040": {
            "authors": [
                {
                    "first": "F. T.",
                    "initial": "F.T.",
                    "last": "Cutts"
                },
                {
                    "first": "S. M.A.",
                    "initial": "S.M.A.",
                    "last": "Zaman"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Enwere"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Jaffar"
                },
                {
                    "first": "O. S.",
                    "initial": "O.S.",
                    "last": "Levine"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Okoko"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Oluwalana"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Vaughan"
                },
                {
                    "first": "S. K.",
                    "initial": "S.K.",
                    "last": "Obaro"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Leach"
                },
                {
                    "first": "K. P.",
                    "initial": "K.P.",
                    "last": "McAdam"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Biney"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Saaka"
                },
                {
                    "first": "U.",
                    "initial": "U.",
                    "last": "Onwuchekwa"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Yallop"
                },
                {
                    "first": "N. F.",
                    "initial": "N.F.",
                    "last": "Pierce"
                },
                {
                    "first": "B. M.",
                    "initial": "B.M.",
                    "last": "Greenwood"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Adegbola"
                }
            ],
            "doi": "10.1016/S0140-6736(05)71876-6",
            "firstpage": "1139",
            "issn": "01406736",
            "lastpage": "1146",
            "pmid": "15794968",
            "pub_year": 2005,
            "title": "Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: Randomised, double-blind, placebo-controlled trial",
            "volume": "365"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Cynthia",
                    "initial": "C.",
                    "last": "Chen"
                },
                {
                    "first": "Francisco",
                    "initial": "F.",
                    "last": "Cervero Liceras"
                },
                {
                    "first": "Stefan",
                    "initial": "S.",
                    "last": "Flasche"
                },
                {
                    "first": "Sucitro",
                    "initial": "S.",
                    "last": "Sidharta"
                },
                {
                    "first": "Joanne",
                    "initial": "J.",
                    "last": "Yoong"
                },
                {
                    "first": "Neisha",
                    "initial": "N.",
                    "last": "Sundaram"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Jit"
                }
            ],
            "doi": "10.1016/S2214-109X(18)30422-4",
            "firstpage": "e58",
            "issn": "2214109X",
            "lastpage": "e67",
            "pmid": "30554762",
            "pub_year": 2019,
            "title": "Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis",
            "volume": "7"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Surasak",
                    "initial": "S.",
                    "last": "Saokaew"
                },
                {
                    "first": "Ajaree",
                    "initial": "A.",
                    "last": "Rayanakorn"
                },
                {
                    "first": "David Bin Chia",
                    "initial": "D.B.C.",
                    "last": "Wu"
                },
                {
                    "first": "Nathorn",
                    "initial": "N.",
                    "last": "Chaiyakunapruk"
                }
            ],
            "doi": "10.1007/s40273-016-0439-3",
            "firstpage": "1211",
            "issn": "11707690",
            "lastpage": "1225",
            "pmid": "27510721",
            "pub_year": 2016,
            "title": "Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review",
            "volume": "34"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Habib",
                    "initial": "H.",
                    "last": "Farooqui"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Jit"
                },
                {
                    "first": "David L.",
                    "initial": "D.L.",
                    "last": "Heymann"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Zodpey"
                }
            ],
            "doi": "10.1371/journal.pone.0129191",
            "issn": "19326203",
            "pmid": "26086700",
            "pub_year": 2015,
            "title": "Burden of severe pneumonia, pneumococcal pneumonia and pneumonia deaths in Indian states: Modelling based estimates",
            "volume": "10"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Hope L.",
                    "initial": "H.L.",
                    "last": "Johnson"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Deloria-Knoll"
                },
                {
                    "first": "Orin S.",
                    "initial": "O.S.",
                    "last": "Levine"
                },
                {
                    "first": "Sonia K.",
                    "initial": "S.K.",
                    "last": "Stoszek"
                },
                {
                    "first": "Laura Freimanis",
                    "initial": "L.F.",
                    "last": "Hance"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Reithinger"
                },
                {
                    "first": "Larry R.",
                    "initial": "L.R.",
                    "last": "Muenz"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                }
            ],
            "doi": "10.1371/journal.pmed.1000348",
            "issn": "15491277",
            "pmid": "20957191",
            "pub_year": 2010,
            "title": "Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: The pneumococcal global serotype project",
            "volume": "7"
        },
        "b0065": null,
        "b0070": null,
        "b0075": {
            "authors": [
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Romero-Steiner"
                },
                {
                    "first": "Carl",
                    "initial": "C.",
                    "last": "Frasch"
                },
                {
                    "first": "Nelydia",
                    "initial": "N.",
                    "last": "Concepcion"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "K\u00e4yhty"
                },
                {
                    "first": "Merja",
                    "initial": "M.",
                    "last": "V\u00e4kev\u00e4inen"
                },
                {
                    "first": "Craig",
                    "initial": "C.",
                    "last": "Laferriere"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Wauters"
                },
                {
                    "first": "Moon H.",
                    "initial": "M.H.",
                    "last": "Nahm"
                },
                {
                    "first": "Mark F.",
                    "initial": "M.F.",
                    "last": "Schinsky"
                },
                {
                    "first": "Brian D.",
                    "initial": "B.D.",
                    "last": "Plikaytis"
                },
                {
                    "first": "George M.",
                    "initial": "G.M.",
                    "last": "Carlone"
                }
            ],
            "doi": "10.1128/CDLI.10.6.1019-1024.2003",
            "firstpage": "1019",
            "issn": "1071412X",
            "lastpage": "1024",
            "pmid": "14607861",
            "pub_year": 2003,
            "title": "Multilaboratory Evaluation of a Viability Assay for Measurement of Opsonophagocytic Antibodies Specific to the Capsular Polysaccharides of Streptococcus pneumoniae",
            "volume": "10"
        },
        "b0080": {
            "authors": [
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "B. D.",
                    "initial": "B.D.",
                    "last": "Plikaytis"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Akkoyunlu"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Antonello"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Ashton"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Blake"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Burton"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Care"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Durant"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Feavers"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Fernsten"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Fievet"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Giardina"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Jansen"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Katz"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Kierstead"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Lee"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Lin"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Maisonneuve"
                },
                {
                    "first": "M. H.",
                    "initial": "M.H.",
                    "last": "Nahm"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Raab"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Romero-Steiner"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Rose"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Schmidt"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Stapleton"
                },
                {
                    "first": "G. M.",
                    "initial": "G.M.",
                    "last": "Carlone"
                }
            ],
            "doi": "10.1128/CVI.05252-11",
            "firstpage": "1728",
            "issn": "15566811",
            "lastpage": "1736",
            "pmid": "21852547",
            "pub_year": 2011,
            "title": "Establishment of a new human pneumococcal standard reference serum, 007sp",
            "volume": "18"
        },
        "b0085": null,
        "b0090": {
            "authors": [
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "J\u00f3dar"
                },
                {
                    "first": "Jay",
                    "initial": "J.",
                    "last": "Butler"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Carlone"
                },
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "K\u00e4yhty"
                },
                {
                    "first": "Keith",
                    "initial": "K.",
                    "last": "Klugman"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Plikaytis"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Siber"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Kohberger"
                },
                {
                    "first": "Ih",
                    "initial": "I.",
                    "last": "Chang"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Cherian"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00230-5",
            "firstpage": "3265",
            "issn": "0264410X",
            "lastpage": "3272",
            "pmid": "12804857",
            "pub_year": 2003,
            "title": "Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants",
            "volume": "21"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Charles E.",
                    "initial": "C.E.",
                    "last": "Rose"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Romero-Steiner"
                },
                {
                    "first": "Robert L.",
                    "initial": "R.L.",
                    "last": "Burton"
                },
                {
                    "first": "George M.",
                    "initial": "G.M.",
                    "last": "Carlone"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Moon H.",
                    "initial": "M.H.",
                    "last": "Nahm"
                },
                {
                    "first": "Lindsey",
                    "initial": "L.",
                    "last": "Ashton"
                },
                {
                    "first": "Mitch",
                    "initial": "M.",
                    "last": "Haston"
                },
                {
                    "first": "Nina",
                    "initial": "N.",
                    "last": "Ekstr\u00f6m"
                },
                {
                    "first": "Raili",
                    "initial": "R.",
                    "last": "Haikala"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "K\u00e4yhty"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Henckaerts"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Durant"
                },
                {
                    "first": "Jan T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                },
                {
                    "first": "Phil",
                    "initial": "P.",
                    "last": "Fernsten"
                },
                {
                    "first": "Xinhong",
                    "initial": "X.",
                    "last": "Yu"
                },
                {
                    "first": "Branda T.",
                    "initial": "B.T.",
                    "last": "Hu"
                },
                {
                    "first": "Kathrin U.",
                    "initial": "K.U.",
                    "last": "Jansen"
                },
                {
                    "first": "Milan",
                    "initial": "M.",
                    "last": "Blake"
                },
                {
                    "first": "Elles R.",
                    "initial": "E.R.",
                    "last": "Simonetti"
                },
                {
                    "first": "Peter W.M.",
                    "initial": "P.W.M.",
                    "last": "Hermans"
                },
                {
                    "first": "Brian D.",
                    "initial": "B.D.",
                    "last": "Plikaytis"
                }
            ],
            "doi": "10.1128/CVI.00370-10",
            "firstpage": "135",
            "issn": "15566811",
            "lastpage": "142",
            "pmid": "21084458",
            "pub_year": 2011,
            "title": "Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera",
            "volume": "18"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Sylvia H.",
                    "initial": "S.H.",
                    "last": "Yeh"
                },
                {
                    "first": "Alejandra",
                    "initial": "A.",
                    "last": "Gurtman"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Hurley"
                },
                {
                    "first": "Stan L.",
                    "initial": "S.L.",
                    "last": "Block"
                },
                {
                    "first": "Richard H.",
                    "initial": "R.H.",
                    "last": "Schwartz"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Patterson"
                },
                {
                    "first": "Kathrin U.",
                    "initial": "K.U.",
                    "last": "Jansen"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Love"
                },
                {
                    "first": "William C.",
                    "initial": "W.C.",
                    "last": "Gruber"
                },
                {
                    "first": "Emilio A.",
                    "initial": "E.A.",
                    "last": "Emini"
                },
                {
                    "first": "Daniel A.",
                    "initial": "D.A.",
                    "last": "Scott"
                }
            ],
            "doi": "10.1542/peds.2009-3027",
            "firstpage": "e493",
            "issn": "00314005",
            "lastpage": "e505",
            "pmid": "20732948",
            "pub_year": 2010,
            "title": "Immunogenicity and safety of 13-Valent pneumococcal conjugate vaccine in infants and toddlers",
            "volume": "126"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Dorothee M.",
                    "initial": "D.M.",
                    "last": "Kieninger"
                },
                {
                    "first": "Kathrin",
                    "initial": "K.",
                    "last": "Kueper"
                },
                {
                    "first": "Katrin",
                    "initial": "K.",
                    "last": "Steul"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Juergens"
                },
                {
                    "first": "Norbert",
                    "initial": "N.",
                    "last": "Ahlers"
                },
                {
                    "first": "Sherryl",
                    "initial": "S.",
                    "last": "Baker"
                },
                {
                    "first": "Kathrin U.",
                    "initial": "K.U.",
                    "last": "Jansen"
                },
                {
                    "first": "Carmel",
                    "initial": "C.",
                    "last": "Devlin"
                },
                {
                    "first": "William C.",
                    "initial": "W.C.",
                    "last": "Gruber"
                },
                {
                    "first": "Emilio A.",
                    "initial": "E.A.",
                    "last": "Emini"
                },
                {
                    "first": "Daniel A.",
                    "initial": "D.A.",
                    "last": "Scott"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.04.008",
            "firstpage": "4192",
            "issn": "0264410X",
            "lastpage": "4203",
            "pmid": "20417262",
            "pub_year": 2010,
            "title": "Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany",
            "volume": "28"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Robert G.",
                    "initial": "R.G.",
                    "last": "Newcombe"
                }
            ],
            "doi": "10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I",
            "firstpage": "873",
            "issn": "02776715",
            "lastpage": "890",
            "pmid": "9595617",
            "pub_year": 1998,
            "title": "Interval estimation for the difference between independent proportions: Comparison of eleven methods",
            "volume": "17"
        },
        "b0115": null,
        "b0120": null,
        "b0125": {
            "authors": [
                {
                    "first": "Bertrand",
                    "initial": "B.",
                    "last": "Chevallier"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Jerzy",
                    "initial": "J.",
                    "last": "Brzostek"
                },
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Knuf"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Bermal"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Aristegui"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Cleerbout"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1097/INF.0b013e318199f62d",
            "firstpage": "S109",
            "issn": "08913668",
            "lastpage": "S118",
            "pmid": "19325447",
            "pub_year": 2009,
            "title": "Safety and reactogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines",
            "volume": "28"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Olubukola T.",
                    "initial": "O.T.",
                    "last": "Idoko"
                },
                {
                    "first": "Robert B.",
                    "initial": "R.B.",
                    "last": "Mboizi"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Okoye"
                },
                {
                    "first": "France",
                    "initial": "F.",
                    "last": "Laudat"
                },
                {
                    "first": "Bubacarr",
                    "initial": "B.",
                    "last": "Ceesay"
                },
                {
                    "first": "John Z.",
                    "initial": "J.Z.",
                    "last": "Liang"
                },
                {
                    "first": "Natacha",
                    "initial": "N.",
                    "last": "Le Dren-Narayanin"
                },
                {
                    "first": "Kathrin U.",
                    "initial": "K.U.",
                    "last": "Jansen"
                },
                {
                    "first": "Alejandra",
                    "initial": "A.",
                    "last": "Gurtman"
                },
                {
                    "first": "Kimberly J.",
                    "initial": "K.J.",
                    "last": "Center"
                },
                {
                    "first": "Daniel A.",
                    "initial": "D.A.",
                    "last": "Scott"
                },
                {
                    "first": "Beate",
                    "initial": "B.",
                    "last": "Kampmann"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Roca"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.04.049",
            "firstpage": "3256",
            "issn": "0264410X",
            "lastpage": "3263",
            "pmid": "28479175",
            "pub_year": 2017,
            "title": "Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial",
            "volume": "35"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Aderonke",
                    "initial": "A.",
                    "last": "Odutola"
                },
                {
                    "first": "Martin O.C.",
                    "initial": "M.O.C.",
                    "last": "Ota"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Antonio"
                },
                {
                    "first": "Ezra O.",
                    "initial": "E.O.",
                    "last": "Ogundare"
                },
                {
                    "first": "Yauba",
                    "initial": "Y.",
                    "last": "Saidu"
                },
                {
                    "first": "Ebenezer",
                    "initial": "E.",
                    "last": "Foster-Nyarko"
                },
                {
                    "first": "Patrick K.",
                    "initial": "P.K.",
                    "last": "Owiafe"
                },
                {
                    "first": "Fatima",
                    "initial": "F.",
                    "last": "Ceesay"
                },
                {
                    "first": "Archibald",
                    "initial": "A.",
                    "last": "Worwui"
                },
                {
                    "first": "Olubukola T.",
                    "initial": "O.T.",
                    "last": "Idoko"
                },
                {
                    "first": "Olumuyiwa",
                    "initial": "O.",
                    "last": "Owolabi"
                },
                {
                    "first": "Abdoulie",
                    "initial": "A.",
                    "last": "Bojang"
                },
                {
                    "first": "Sheikh",
                    "initial": "S.",
                    "last": "Jarju"
                },
                {
                    "first": "Isatou",
                    "initial": "I.",
                    "last": "Drammeh"
                },
                {
                    "first": "Beate",
                    "initial": "B.",
                    "last": "Kampmann"
                },
                {
                    "first": "Brian M.",
                    "initial": "B.M.",
                    "last": "Greenwood"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Alderson"
                },
                {
                    "first": "Magali",
                    "initial": "M.",
                    "last": "Traskine"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Devos"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Schoonbroodt"
                },
                {
                    "first": "Kristien",
                    "initial": "K.",
                    "last": "Swinnen"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "Kurt",
                    "initial": "K.",
                    "last": "Dobbelaere"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.03.071",
            "firstpage": "2531",
            "issn": "0264410X",
            "lastpage": "2542",
            "pmid": "28389097",
            "pub_year": 2017,
            "title": "Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study",
            "volume": "35"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Elizabeth A.",
                    "initial": "E.A.",
                    "last": "Clutterbuck"
                },
                {
                    "first": "Rajeka",
                    "initial": "R.",
                    "last": "Lazarus"
                },
                {
                    "first": "Ly Mee",
                    "initial": "L.M.",
                    "last": "Yu"
                },
                {
                    "first": "Jaclyn",
                    "initial": "J.",
                    "last": "Bowman"
                },
                {
                    "first": "Elizabeth A.L.",
                    "initial": "E.A.L.",
                    "last": "Bateman"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Diggle"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Angus"
                },
                {
                    "first": "Tim E.",
                    "initial": "T.E.",
                    "last": "Peto"
                },
                {
                    "first": "Peter C.",
                    "initial": "P.C.",
                    "last": "Beverley"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Mant"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1093/infdis/jis212",
            "firstpage": "1408",
            "issn": "00221899",
            "lastpage": "1416",
            "pmid": "22457293",
            "pub_year": 2012,
            "title": "Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells",
            "volume": "205"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                },
                {
                    "first": "Kirsten P.",
                    "initial": "K.P.",
                    "last": "Perrett"
                },
                {
                    "first": "Peter C.",
                    "initial": "P.C.",
                    "last": "Beverley"
                }
            ],
            "doi": "10.1038/nri2494",
            "firstpage": "213",
            "issn": "14741733",
            "lastpage": "220",
            "pmid": "19214194",
            "pub_year": 2009,
            "title": "Maintaining protection against invasive bacteria with protein- polysaccharide conjugate vaccines",
            "volume": "9"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moberley"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Holden"
                },
                {
                    "first": "David Paul",
                    "initial": "D.P.",
                    "last": "Tatham"
                },
                {
                    "first": "Ross M.",
                    "initial": "R.M.",
                    "last": "Andrews"
                }
            ],
            "doi": "10.1002/14651858.CD000422.pub3",
            "issn": "1469493X",
            "pmid": "23440780",
            "pub_year": 2013,
            "title": "Vaccines for preventing pneumococcal infection in adults",
            "volume": "2013"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Wen qi",
                    "initial": "W.q.",
                    "last": "Diao"
                },
                {
                    "first": "Ning",
                    "initial": "N.",
                    "last": "Shen"
                },
                {
                    "first": "Pan xi",
                    "initial": "P.x.",
                    "last": "Yu"
                },
                {
                    "first": "Bei bei",
                    "initial": "B.b.",
                    "last": "Liu"
                },
                {
                    "first": "Bei",
                    "initial": "B.",
                    "last": "He"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.02.023",
            "firstpage": "1496",
            "issn": "0264410X",
            "lastpage": "1503",
            "pmid": "26899376",
            "pub_year": 2016,
            "title": "Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials",
            "volume": "34"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Nirma Khatri",
                    "initial": "N.K.",
                    "last": "Vadlamudi"
                },
                {
                    "first": "Kamalpreet",
                    "initial": "K.",
                    "last": "Parhar"
                },
                {
                    "first": "Kim Lorenzo",
                    "initial": "K.L.",
                    "last": "Altre Malana"
                },
                {
                    "first": "Amy",
                    "initial": "A.",
                    "last": "Kang"
                },
                {
                    "first": "Fawziah",
                    "initial": "F.",
                    "last": "Marra"
                }
            ],
            "doi": "10.1016/j.vaccine.2019.01.014",
            "firstpage": "1021",
            "issn": "0264410X",
            "lastpage": "1029",
            "pmid": "30685252",
            "pub_year": 2019,
            "title": "Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis",
            "volume": "37"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Roca"
                },
                {
                    "first": "Philip C.",
                    "initial": "P.C.",
                    "last": "Hill"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Townend"
                },
                {
                    "first": "Uzo",
                    "initial": "U.",
                    "last": "Egere"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Antonio"
                },
                {
                    "first": "Abdoulie",
                    "initial": "A.",
                    "last": "Bojang"
                },
                {
                    "first": "Abiodun",
                    "initial": "A.",
                    "last": "Akisanya"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Litchfield"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Nsekpong"
                },
                {
                    "first": "Claire",
                    "initial": "C.",
                    "last": "Oluwalana"
                },
                {
                    "first": "Stephen R.C.",
                    "initial": "S.R.C.",
                    "last": "Howie"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Greenwood"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Adegbola"
                }
            ],
            "doi": "10.1371/journal.pmed.1001107",
            "issn": "15491277",
            "pmid": "22028630",
            "pub_year": 2011,
            "title": "Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: A cluster-randomized trial",
            "volume": "8"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Philip C.",
                    "initial": "P.C.",
                    "last": "Hill"
                },
                {
                    "first": "Abiodun",
                    "initial": "A.",
                    "last": "Akisanya"
                },
                {
                    "first": "Kawsu",
                    "initial": "K.",
                    "last": "Sankareh"
                },
                {
                    "first": "Yin Bun",
                    "initial": "Y.B.",
                    "last": "Cheung"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Saaka"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Lahai"
                },
                {
                    "first": "Brian M.",
                    "initial": "B.M.",
                    "last": "Greenwood"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Adegbola"
                }
            ],
            "doi": "10.1086/506941",
            "firstpage": "673",
            "issn": "10584838",
            "lastpage": "679",
            "pmid": "16912937",
            "pub_year": 2006,
            "title": "Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers",
            "volume": "43"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "Noga",
                    "initial": "N.",
                    "last": "Givon-Lavi"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Greenberg"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Fritzell"
                },
                {
                    "first": "Claire Anne",
                    "initial": "C.A.",
                    "last": "Siegrist"
                }
            ],
            "doi": "10.1086/652006",
            "firstpage": "1570",
            "issn": "00221899",
            "lastpage": "1579",
            "pmid": "20384496",
            "pub_year": 2010,
            "title": "Nasopharyngeal carriage of streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy",
            "volume": "201"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Merja",
                    "initial": "M.",
                    "last": "V\u00e4kev\u00e4inen"
                },
                {
                    "first": "Anu",
                    "initial": "A.",
                    "last": "Soininen"
                },
                {
                    "first": "Marilla",
                    "initial": "M.",
                    "last": "Lucero"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Nohynek"
                },
                {
                    "first": "Kari",
                    "initial": "K.",
                    "last": "Auranen"
                },
                {
                    "first": "P. Helena",
                    "initial": "P.H.",
                    "last": "M\u00e4kel\u00e4"
                },
                {
                    "first": "Gail",
                    "initial": "G.",
                    "last": "Williams"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "K\u00e4yhty"
                }
            ],
            "doi": "10.1016/j.jpeds.2010.04.071",
            "firstpage": "778",
            "issn": "00223476",
            "lastpage": "e1",
            "pmid": "20547399",
            "pub_year": 2010,
            "title": "Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination",
            "volume": "157"
        },
        "b0185": null,
        "b0190": {
            "authors": [
                {
                    "first": "Johannes",
                    "initial": "J.",
                    "last": "Tr\u00fcck"
                },
                {
                    "first": "Sena",
                    "initial": "S.",
                    "last": "Jawad"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Roalfe"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                },
                {
                    "first": "Merryn",
                    "initial": "M.",
                    "last": "Voysey"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1097/INF.0000000000001180",
            "firstpage": "787",
            "issn": "08913668",
            "lastpage": "793",
            "pmid": "27088583",
            "pub_year": 2016,
            "title": "The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy",
            "volume": "35"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Ingrid",
                    "initial": "I.",
                    "last": "Urbancikova"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Roalfe"
                },
                {
                    "first": "Karolina",
                    "initial": "K.",
                    "last": "Prymulova"
                },
                {
                    "first": "Pavel",
                    "initial": "P.",
                    "last": "Kosina"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.07.103",
            "firstpage": "5186",
            "issn": "0264410X",
            "lastpage": "5193",
            "pmid": "28797727",
            "pub_year": 2017,
            "title": "Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia",
            "volume": "35"
        },
        "b0200": null,
        "b0205": {
            "authors": [
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Jacek",
                    "initial": "J.",
                    "last": "Wysocki"
                },
                {
                    "first": "Bertrand",
                    "initial": "B.",
                    "last": "Chevallier"
                },
                {
                    "first": "Aino",
                    "initial": "A.",
                    "last": "Karvonen"
                },
                {
                    "first": "Hanna",
                    "initial": "H.",
                    "last": "Czajka"
                },
                {
                    "first": "Jean Pierre",
                    "initial": "J.P.",
                    "last": "Ars\u00e8ne"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Ilse",
                    "initial": "I.",
                    "last": "Dieussaert"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1097/INF.0b013e318199f8ef",
            "firstpage": "S66",
            "issn": "08913668",
            "lastpage": "S76",
            "pmid": "19325449",
            "pub_year": 2009,
            "title": "Immunogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine",
            "volume": "28"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Arto A.",
                    "initial": "A.A.",
                    "last": "Palmu"
                },
                {
                    "first": "Jukka",
                    "initial": "J.",
                    "last": "Jokinen"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Heta",
                    "initial": "H.",
                    "last": "Nieminen"
                },
                {
                    "first": "Esa",
                    "initial": "E.",
                    "last": "Ruokokoski"
                },
                {
                    "first": "Lotta",
                    "initial": "L.",
                    "last": "Siira"
                },
                {
                    "first": "Taneli",
                    "initial": "T.",
                    "last": "Puumalainen"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Marjan",
                    "initial": "M.",
                    "last": "Hezareh"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Moreira"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                },
                {
                    "first": "Terhi M.",
                    "initial": "T.M.",
                    "last": "Kilpi"
                }
            ],
            "doi": "10.1016/S0140-6736(12)61854-6",
            "firstpage": "214",
            "issn": "01406736",
            "lastpage": "222",
            "pub_year": 2013,
            "title": "Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: A cluster randomised trial",
            "volume": "381"
        },
        "b0215": {
            "authors": [
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Schuerman"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Wysocki"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Tejedor"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Knuf"
                },
                {
                    "first": "K. H.",
                    "initial": "K.H.",
                    "last": "Kim"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Poolman"
                }
            ],
            "doi": "10.1128/CVI.05313-11",
            "firstpage": "2161",
            "issn": "15566811",
            "lastpage": "2167",
            "pmid": "21994351",
            "pub_year": 2011,
            "title": "Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption",
            "volume": "18"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Alienke J.",
                    "initial": "A.J.",
                    "last": "Wijmenga-Monsuur"
                },
                {
                    "first": "Els",
                    "initial": "E.",
                    "last": "Van Westen"
                },
                {
                    "first": "Mirjam J.",
                    "initial": "M.J.",
                    "last": "Knol"
                },
                {
                    "first": "Riet M.C.",
                    "initial": "R.M.C.",
                    "last": "Jongerius"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Zancolli"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Pieter G.M.",
                    "initial": "P.G.M.",
                    "last": "Van Gageldonk"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Tcherniaeva"
                },
                {
                    "first": "Guy A.M.",
                    "initial": "G.A.M.",
                    "last": "Berbers"
                },
                {
                    "first": "Nynke Y.",
                    "initial": "N.Y.",
                    "last": "Rots"
                }
            ],
            "doi": "10.1371/journal.pone.0144739",
            "issn": "19326203",
            "pmid": "26658902",
            "pub_year": 2015,
            "title": "Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants",
            "volume": "10"
        }
    },
    "body_text": [
        {
            "endOffset": 41388,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "The GMFR ratios ranged from 0.33 (95% CI: 0.15\u20130.77) for serotype 19A to 1.50 (95% CI: 0.78\u20132.78) for serotype 14 and were higher for serotypes 5, 9V, and 19A following PCV13 than following SIIPL-PCV.",
            "startOffset": 41188,
            "title": "Toddlers"
        },
        {
            "endOffset": 44281,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0090",
            "sentence": "The magnitude of the booster response was greater for five serotypes (1, 6B, 9V, 19A, and 23F) following SIIPL-PCV and for serotype 5 following PCV13 (Table 6).",
            "startOffset": 44121,
            "title": "Booster responses"
        },
        {
            "endOffset": 54999,
            "parents": [],
            "secId": "s0110",
            "sentence": "EC, SL, AOB, MO, AU, MBH, AT and BK contributed to study conduct.",
            "startOffset": 54934,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 32964,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The sample size of each cohort was chosen to provide sufficient data to support age-de-escalation and, subsequently, safety and immunogenicity data to support decisions regarding further evaluation of SIIPL-PCV in phase 3 trials.",
            "startOffset": 32735,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 43368,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "The responses were lower for the four remaining serotypes following SIIPL-PCV than following PCV13 administration (Table 5).",
            "startOffset": 43244,
            "title": "Primary series responses"
        },
        {
            "endOffset": 29671,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All study vaccines were administered intramuscularly using a 23G 25 mm needle into the mid-deltoid of the subject\u2019s non-dominant arm in adults and the mid-thigh in toddlers and infants.",
            "startOffset": 29486,
            "title": "Study design and participants"
        },
        {
            "endOffset": 42943,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "Based on OPA titers, between 93.8% (95% CI: 69.8\u201399.8) and 100% of infants seroresponded following SIIPL-PCV compared to between 84.6% (95% CI: 54.6\u201398.1) and 100% following PCV13.",
            "startOffset": 42763,
            "title": "Primary series responses"
        },
        {
            "endOffset": 36487,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "Injection-site swelling occurred in 10.7% of those receiving SIIPL-PCV compared to 1.8% of those receiving PCV13.",
            "startOffset": 36374,
            "title": "Toddlers"
        },
        {
            "endOffset": 45951,
            "parents": [],
            "secId": "s0100",
            "sentence": "No noteworthy safety signals were identified.",
            "startOffset": 45906,
            "title": "Discussion"
        },
        {
            "endOffset": 47702,
            "parents": [],
            "secId": "s0100",
            "sentence": "Nonetheless, the adult data support further assessment of SIIPL-PCV although they should be interpreted with caution given the small number of subjects evaluated.",
            "startOffset": 47540,
            "title": "Discussion"
        },
        {
            "endOffset": 51327,
            "parents": [],
            "secId": "s0100",
            "sentence": "The effects of past or concurrent carriage should again be borne in mind although, given the double-blind, randomized design, are likely to become less important as the group size increases.",
            "startOffset": 51137,
            "title": "Discussion"
        },
        {
            "endOffset": 51907,
            "parents": [],
            "secId": "s0100",
            "sentence": "Also, there was a substantial GMFR in antibody responses from pre- to post-booster vaccination for all serotypes in both groups.",
            "startOffset": 51779,
            "title": "Discussion"
        },
        {
            "endOffset": 30937,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Any ongoing reactogenicity at the end of the follow-up period (e.g., persistent injection-site swelling) was reported as an unsolicited AE and followed up accordingly.",
            "startOffset": 30770,
            "title": "Assessments"
        },
        {
            "endOffset": 35354,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "One infant in the PCV13 group withdrew from the study; therefore, 199 of 200 (99.5%) infants completed the study per protocol (Fig. 2C).",
            "startOffset": 35218,
            "title": "Disposition and demographics"
        },
        {
            "endOffset": 39044,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "The only SAE reported in more than two infants was bronchiolitis (three infants [four events] in the SIIPL-PCV group and one infant [one event] in the PCV13 group).",
            "startOffset": 38880,
            "title": "Infants"
        },
        {
            "endOffset": 48927,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 48926,
                    "startOffset": 48922
                }
            },
            "secId": "s0100",
            "sentence": "The responses to boosting with the licensed 10-valent PCV (Synflorix\u00ae, GlaxoSmithKline) following PCV13 priming have been shown to be generally lower than the responses to boosting with PCV13 [38].",
            "startOffset": 48730,
            "title": "Discussion"
        },
        {
            "endOffset": 50313,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 50312,
                    "startOffset": 50305
                },
                "b0105": {
                    "endOffset": 50312,
                    "startOffset": 50305
                }
            },
            "secId": "s0100",
            "sentence": "While generally higher in the PCV13 group, IgG GMCs following SIIPL-PCV were above 1 \u00b5g/mL for all 10 serotypes, and the point estimate for the GMC ratio comparing SIIPL-PCV with PCV13 was below the 0.5 non-inferiority margin used in previous trials for only three serotypes (6B, 9V, and 19A) [20,21].",
            "startOffset": 50012,
            "title": "Discussion"
        },
        {
            "endOffset": 37832,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "In the infant cohort, no severe solicited injection-site reactions were reported.",
            "startOffset": 37751,
            "title": "Infants"
        },
        {
            "endOffset": 23460,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 23459,
                    "startOffset": 23454
                },
                "b0020": {
                    "endOffset": 23459,
                    "startOffset": 23454
                },
                "b0025": {
                    "endOffset": 23459,
                    "startOffset": 23454
                },
                "b0030": {
                    "endOffset": 23459,
                    "startOffset": 23454
                },
                "b0035": {
                    "endOffset": 23459,
                    "startOffset": 23454
                },
                "b0040": {
                    "endOffset": 23459,
                    "startOffset": 23454
                }
            },
            "secId": "s0005",
            "sentence": "Pneumococcal conjugate vaccines (PCVs) are highly effective at protecting children from IPD and their introduction has substantially reduced morbidity and mortality from pneumococcal disease in children, including in The Gambia where this study was undertaken [3\u20138].",
            "startOffset": 23194,
            "title": "Introduction"
        },
        {
            "endOffset": 27999,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "During the primary study, subjects, parents, and all study staff except the unblinded nurses were blinded to treatment assignment.",
            "startOffset": 27869,
            "title": "Study design and participants"
        },
        {
            "endOffset": 32699,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The analysis of this phase 1/2 study was descriptive.",
            "startOffset": 32646,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 36241,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0045",
            "sentence": "Five vaccine-related TEAEs occurred in adults (one in the SIIPL-PCV group [pain in the axilla] and four in the PPSV23 group), all of which were mild.",
            "startOffset": 36092,
            "title": "Adults"
        },
        {
            "endOffset": 43243,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "The serotype-specific OPA GMTs following the primary series were comparable for the two vaccines for six (1, 5, 6B, 14, 19F, and 23F) of 10 serotypes.",
            "startOffset": 43093,
            "title": "Primary series responses"
        },
        {
            "endOffset": 48644,
            "parents": [],
            "secId": "s0100",
            "sentence": "In addition, the toddlers in this study had all received three priming doses of PCV13 as part of the Gambian EPI schedule.",
            "startOffset": 48522,
            "title": "Discussion"
        },
        {
            "endOffset": 37873,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "One severe fever occurred in each group.",
            "startOffset": 37833,
            "title": "Infants"
        },
        {
            "endOffset": 53402,
            "parents": [],
            "secId": "s0100",
            "sentence": "Furthermore, not only IgG but also functional antibodies were measured.",
            "startOffset": 53331,
            "title": "Discussion"
        },
        {
            "endOffset": 52123,
            "parents": [],
            "secId": "s0100",
            "sentence": "While the IgG GMCs following the primary immunization series were higher for six serotypes following PCV13, these differences tended to be reduced or even reversed pre-booster, and additionally reduced post-booster.",
            "startOffset": 51908,
            "title": "Discussion"
        },
        {
            "endOffset": 35640,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Treatment groups in all cohorts were well-balanced with respect to age, sex, weight, and height/length (Table 1; adult and toddler data not shown).",
            "startOffset": 35493,
            "title": "Disposition and demographics"
        },
        {
            "endOffset": 38611,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "The most common TEAEs in infants were injection-site reactions related to co-administered DTwP-HepB-Hib vaccine, and URTIs (Table 3).",
            "startOffset": 38478,
            "title": "Infants"
        },
        {
            "endOffset": 23916,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 23915,
                    "startOffset": 23909
                },
                "b0050": {
                    "endOffset": 23915,
                    "startOffset": 23909
                }
            },
            "secId": "s0005",
            "sentence": "The high cost of PCVs makes them difficult for low- and middle-income countries (LMICs) to afford without considerable financial assistance, and places a high financial burden on countries graduating from support for vaccine purchase from Gavi, the Vaccine Alliance [9,10].",
            "startOffset": 23643,
            "title": "Introduction"
        },
        {
            "endOffset": 41659,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "The response to serotype 14 alone was higher in the SIIPL-PCV group.",
            "startOffset": 41591,
            "title": "Toddlers"
        },
        {
            "endOffset": 44478,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0090",
            "sentence": "Only the GMC against serotypes 19A and 19F remained higher in the PCV13 group than in the SIIPL-PCV group following the booster immunization (GMCR 19A: 0.44 [0.27 \u2013 0.72]; 19F 0.65 [0.43 \u2013 0.99]).",
            "startOffset": 44282,
            "title": "Booster responses"
        },
        {
            "endOffset": 51136,
            "parents": [],
            "secId": "s0100",
            "sentence": "Thus, while the responses generated following the SIIPL-PCV primary series tended to be somewhat lower than those generated following the PCV13 primary series, they were considered to be robust with both vaccines.",
            "startOffset": 50923,
            "title": "Discussion"
        },
        {
            "endOffset": 43093,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "In both groups, the seroresponse rates based on OPA titers were lowest against serotype 1 but the responses between groups were comparable (Table 5).",
            "startOffset": 42944,
            "title": "Primary series responses"
        },
        {
            "endOffset": 55418,
            "parents": [],
            "secId": "s0115",
            "sentence": "The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the foundation.",
            "startOffset": 55276,
            "title": "Funding"
        },
        {
            "endOffset": 40101,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0070",
            "sentence": "The GMCs were higher following SIIPL-PCV for serotypes 6A and 6B (GMC ratio 4.69 [95% CI: 2.16\u201310.20] and 2.22 [95% CI: 1.02\u20134.84], respectively) and were higher following PPSV23 for serotypes 1 and 9V (GMC ratio 0.31 [95% CI: 0.15\u20130.64] and 0.56 [95% CI: 0.34\u20130.95], respectively).",
            "startOffset": 39819,
            "title": "Adults"
        },
        {
            "endOffset": 30769,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Injection-site and systemic reactogenicity was solicited in clinic one hour (h) (30 min post-booster) and daily for 7d post-vaccination (6d post-booster) and was severity-graded (one to four) per protocol definitions.",
            "startOffset": 30552,
            "title": "Assessments"
        },
        {
            "endOffset": 36373,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "Injection-site tenderness was elicited in comparable proportions between groups (Table S2).",
            "startOffset": 36282,
            "title": "Toddlers"
        },
        {
            "endOffset": 46283,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 46282,
                    "startOffset": 46272
                },
                "b0125": {
                    "endOffset": 46282,
                    "startOffset": 46272
                },
                "b0130": {
                    "endOffset": 46282,
                    "startOffset": 46272
                },
                "b0135": {
                    "endOffset": 46282,
                    "startOffset": 46272
                }
            },
            "secId": "s0100",
            "sentence": "The rates of injection-site and systemic reactogenicity following SIIPL-PCV were broadly comparable to those following the licensed comparator vaccines (PPSV23 in adults, PCV13 in toddlers and infants) and were consistent with rates previously reported in trials of the licensed PCVs in infants, including in The Gambia [21,25\u201327].",
            "startOffset": 45952,
            "title": "Discussion"
        },
        {
            "endOffset": 48320,
            "parents": [],
            "secId": "s0100",
            "sentence": "As in the adult cohort, the potential impact of differential past or concurrent nasopharyngeal carriage of given pneumococcal serotypes on the immune responses generated should be borne in mind given the limited sample size.",
            "startOffset": 48096,
            "title": "Discussion"
        },
        {
            "endOffset": 32135,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 32134,
                    "startOffset": 32127
                },
                "b0080": {
                    "endOffset": 32134,
                    "startOffset": 32127
                }
            },
            "secId": "s0020",
            "sentence": "Immunogenicity was evaluated by the World Health Organization (WHO) Pneumococcal Serology Reference Laboratory, University College London, United Kingdom, using a validated enzyme-linked immunosorbent assay to quantify pneumococcal serotype-specific immunoglobulin G (IgG) concentrations, and a four-fold multiplexed opsonophagocytic assay (OPA) to quantify functional immune responses [15,16].",
            "startOffset": 31741,
            "title": "Assessments"
        },
        {
            "endOffset": 44982,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0095",
            "sentence": "A single infant was below the protective threshold for Hib following co-administration with PCV13.",
            "startOffset": 44884,
            "title": "Responses to co-administered EPI vaccines"
        },
        {
            "endOffset": 32523,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "IgG concentrations were measured in the infant cohort for each component of the co-administered DTwP-HepB-Hib vaccine at Public Health England laboratories, United Kingdom.",
            "startOffset": 32351,
            "title": "Assessments"
        },
        {
            "endOffset": 40428,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0070",
            "sentence": "OPA GMTs were also higher for serotypes 6A and 6B following SIIPL-PCV (GMT ratio 3.48 [95% CI 1.71\u20136.37] and 3.15 [95% CI: 1.76\u20135.61], respectively) and for serotype 1 alone following PPSV23 (GMT ratio 0.22 [95% CI: 0.07\u20130.99]) (Table S3).",
            "startOffset": 40189,
            "title": "Adults"
        },
        {
            "endOffset": 38168,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "In the booster phase, two of 49 infants in the SIIPL-PCV group (4.1%) and one of 47 infants in the PCV13 group (2.1%) had a severe fever.",
            "startOffset": 38031,
            "title": "Infants"
        },
        {
            "endOffset": 50650,
            "parents": [],
            "secId": "s0100",
            "sentence": "In particular, the immune responses to three serotypes (6B, 19F, and 23F) that were lower in the SIIPL-PCV group based on IgG GMCs were similar between groups based on OPA GMTs.",
            "startOffset": 50473,
            "title": "Discussion"
        },
        {
            "endOffset": 24643,
            "parents": [],
            "secId": "s0005",
            "sentence": "Furthermore, SIIPL has lowered SIIPL-PCV\u2019s manufacturing costs by optimizing three critical components of the manufacturing process: carrier protein production, polysaccharide production, and conjugation efficiency.",
            "startOffset": 24428,
            "title": "Introduction"
        },
        {
            "endOffset": 34236,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "In the infant cohort, a booster response was defined by comparing the GMC 28d post-booster with the GMC 28d post-primary series.",
            "startOffset": 34108,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 39818,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0070",
            "sentence": "In adults, the serotype-specific IgG GMC ranged from 3.56 \u00b5g/mL (95% CI: 1.89\u20136.72) for serotype 5 to 48.23 \u00b5g/mL (95% CI: 28.87\u201380.59) for serotype 14 following SIIPL-PCV, and from 3.64 \u00b5g/mL (95% CI: 2.41\u20135.52) for serotype 6A to 44.78 \u00b5g/mL (95% CI: 31.04\u201364.59) for serotype 14 following PPSV23.",
            "startOffset": 39519,
            "title": "Adults"
        },
        {
            "endOffset": 29417,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Lot 209E3001 was used throughout.",
            "startOffset": 29384,
            "title": "Study design and participants"
        },
        {
            "endOffset": 27573,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Vaccine assignment was indicated in individual, sequentially-numbered, sealed, opaque, tamper-evident envelopes.",
            "startOffset": 27461,
            "title": "Study design and participants"
        },
        {
            "endOffset": 31219,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Unsolicited AEs were recorded from consent through 28d (adult and toddler cohorts) or 84d (infant primary phase) following vaccination.",
            "startOffset": 31084,
            "title": "Assessments"
        },
        {
            "endOffset": 31741,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Clinical laboratory evaluations and vital signs were toxicity-graded per protocol definitions and assessed for clinical significance by a study clinician.",
            "startOffset": 31587,
            "title": "Assessments"
        },
        {
            "endOffset": 36782,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "There were no other notable differences in systemic reactogenicity between groups.",
            "startOffset": 36700,
            "title": "Toddlers"
        },
        {
            "endOffset": 52433,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 52432,
                    "startOffset": 52428
                }
            },
            "secId": "s0100",
            "sentence": "Serotype-specific differences between PCV13 and SIIPL-PCV in the kinetics of the immune response have been observed between PCV13 and the licensed 10-valent vaccine in other studies and warrant further assessment [44].",
            "startOffset": 52215,
            "title": "Discussion"
        },
        {
            "endOffset": 53129,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 53128,
                    "startOffset": 53124
                }
            },
            "secId": "s0100",
            "sentence": "The infant 6-, 10-, and 14-week schedule is in keeping with the requirements of the Target Product Profile for the Advanced Market Commitment for PCV, which sets out the specifications that new vaccines must meet to secure future purchase for Gavi-eligible countries [41].",
            "startOffset": 52857,
            "title": "Discussion"
        },
        {
            "endOffset": 33718,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Safety endpoints were injection-site and systemic reactogenicity and TEAEs and were evaluated descriptively.",
            "startOffset": 33610,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 54135,
            "parents": [],
            "secId": "s0100",
            "sentence": "The analysis is primarily descriptive.",
            "startOffset": 54097,
            "title": "Discussion"
        },
        {
            "endOffset": 25417,
            "parents": [],
            "secId": "s0005",
            "sentence": "In infants, PCV was co-administered with the routine Expanded Program on Immunization (EPI) vaccines.",
            "startOffset": 25316,
            "title": "Introduction"
        },
        {
            "endOffset": 54674,
            "parents": [],
            "secId": "s0105",
            "sentence": "The safety, tolerability and immunogenicity data generated support the future evaluation of SIIPL-PCV in a phase 3, non-inferiority, licensure trial in infants.",
            "startOffset": 54514,
            "title": "Conclusions"
        },
        {
            "endOffset": 41059,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "The GMFRs following SIIPL-PCV ranged from 3.82 (95% CI: 2.48\u20137.34) for serotype 5 to 9.91 (95% CI: 5.58\u201322.32) for serotype 6A.",
            "startOffset": 40932,
            "title": "Toddlers"
        },
        {
            "endOffset": 41954,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "In infants, the point estimates for seroresponse rates were >90% for all serotypes following the three-dose primary series of PCV13 and were >90%, and comparable to PCV13 responses, for 8 of 10 serotypes following the same SIIPL-PCV schedule (Table 5).",
            "startOffset": 41702,
            "title": "Primary series responses"
        },
        {
            "endOffset": 35493,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "A total of 96 infants (49 SIIPL-PCV, 47 PCV13) received a booster dose of study vaccine and contributed to the booster analysis (Fig. 2D).",
            "startOffset": 35355,
            "title": "Disposition and demographics"
        },
        {
            "endOffset": 54022,
            "parents": [],
            "secId": "s0100",
            "sentence": "Thus, undertaking the study in The Gambia, a low-income country in West Africa, ensures that the data are directly applicable to settings that stand to benefit from a vaccine such as SIIPL-PCV in the future.",
            "startOffset": 53815,
            "title": "Discussion"
        },
        {
            "endOffset": 29067,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Participants were also asked to contact the study team with any health-related concerns at any time during the study and, under such circumstances, were seen by a study clinician who provided treatment or referral if necessary, and recorded all adverse events (AEs).",
            "startOffset": 28801,
            "title": "Study design and participants"
        },
        {
            "endOffset": 54502,
            "parents": [],
            "secId": "s0100",
            "sentence": "The provisos present in the interpretation of the findings are as expected and will be addressed in future phase 3 trials.",
            "startOffset": 54380,
            "title": "Discussion"
        },
        {
            "endOffset": 46547,
            "parents": [],
            "secId": "s0100",
            "sentence": "Where numerical treatment-group differences were apparent, they are likely to reflect chance events given an absence of consistent trends between age cohorts or across different vaccine doses in infants, reflecting the limited sample size of this phase 1/2 trial.",
            "startOffset": 46284,
            "title": "Discussion"
        },
        {
            "endOffset": 28364,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Adults and toddlers underwent four clinic visits (screening, vaccination, and follow-up at 7 days [d] and 28d post-vaccination).",
            "startOffset": 28236,
            "title": "Study design and participants"
        },
        {
            "endOffset": 38477,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "Nearly all infants had at least one TEAE (97.0% in the SIIPL-PCV group versus 96.0% in the PCV13 group).",
            "startOffset": 38373,
            "title": "Infants"
        },
        {
            "endOffset": 43811,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0090",
            "sentence": "A substantial booster response was observed for all serotypes following PCV13 and for all serotypes except serotype 5 following SIIPL-PCV (Table 6).",
            "startOffset": 43663,
            "title": "Booster responses"
        },
        {
            "endOffset": 37028,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "The proportion of toddlers with at least one TEAE was similar between groups.",
            "startOffset": 36951,
            "title": "Toddlers"
        },
        {
            "endOffset": 41481,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "The OPA GMTs following the booster vaccination in toddlers were broadly comparable (Table 4).",
            "startOffset": 41388,
            "title": "Toddlers"
        },
        {
            "endOffset": 55090,
            "parents": [],
            "secId": "s0110",
            "sentence": "SL, EC, MRA, JF, DHW, RD and VS contributed to data interpretation.",
            "startOffset": 55023,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 28075,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The infant booster phase (added after study unblinding) was single-blinded.",
            "startOffset": 28000,
            "title": "Study design and participants"
        },
        {
            "endOffset": 49127,
            "parents": [],
            "secId": "s0100",
            "sentence": "These differences, however, may have been explained by the different carrier protein (Haemophilus influenzae-derived protein D) conjugated to the affected serotypes in the licensed 10-valent vaccine.",
            "startOffset": 48928,
            "title": "Discussion"
        },
        {
            "endOffset": 47218,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 47217,
                    "startOffset": 47204
                },
                "b0070": {
                    "endOffset": 47217,
                    "startOffset": 47204
                },
                "b0140": {
                    "endOffset": 47217,
                    "startOffset": 47204
                },
                "b0145": {
                    "endOffset": 47217,
                    "startOffset": 47204
                }
            },
            "secId": "s0100",
            "sentence": "Given the underlying biological differences in the nature of the immune responses to polysaccharide (PPSV23) and polysaccharide-conjugate vaccines (SIIPL-PCV) as well as the different quantities of polysaccharide antigens in the two vaccines, direct comparison of the serological responses they generate has some limitations [13,14,28,29].",
            "startOffset": 46879,
            "title": "Discussion"
        },
        {
            "endOffset": 30107,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was conducted in accordance with Good Clinical Practice and the Declaration of Helsinki, and registered with ClinicalTrials.gov (NCT02308540).",
            "startOffset": 29955,
            "title": "Study design and participants"
        },
        {
            "endOffset": 36699,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "All injection-site reactions were mild or moderate, and generally resolved within 24\u201348 h. Drowsiness was reported in 10.7% of toddlers who received SIIPL-PCV and was not reported following PCV13 administration.",
            "startOffset": 36488,
            "title": "Toddlers"
        },
        {
            "endOffset": 26451,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All toddlers had previously received three-doses of PCV13 according to the two-, three-, and four-month EPI schedule in The Gambia.",
            "startOffset": 26320,
            "title": "Study design and participants"
        },
        {
            "endOffset": 28236,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The investigator and study clinicians were unblinded to group assignment but all other site staff, laboratory personnel, and subjects\u2019 parents remained blinded.",
            "startOffset": 28076,
            "title": "Study design and participants"
        },
        {
            "endOffset": 37422,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "Two toddlers in the SIIPL-PCV group and one in the PCV13 group had a mild or moderate vaccine-related TEAE (mild diarrhea and moderate rash following SIIPL-PCV).",
            "startOffset": 37261,
            "title": "Toddlers"
        },
        {
            "endOffset": 49283,
            "parents": [],
            "secId": "s0100",
            "sentence": "Therefore, any role of the different priming vaccine in the somewhat lower responses to SIIPL-PCV, which uses the same CRM197 carrier as PCV13, is unclear.",
            "startOffset": 49128,
            "title": "Discussion"
        },
        {
            "endOffset": 25762,
            "parents": [],
            "secId": "s0005",
            "sentence": "The immune responses to components of co-administered pentavalent vaccine (diphtheria, tetanus, whole-cell pertussis, hepatitis B, and Haemophilus influenzae type b [DTwP-HepB-Hib]), and the safety, tolerability, and immunogenicity of a booster dose of SIIPL-PCV given to a subset of infants between 10 and 14 months old were also investigated.",
            "startOffset": 25418,
            "title": "Introduction"
        },
        {
            "endOffset": 34904,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Immunogenicity assays reported as below the limit of quantification (LOQ) were assigned a value of one-half the LOQ; otherwise, no imputation was conducted.",
            "startOffset": 34748,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 53814,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 53733,
                    "startOffset": 53729
                }
            },
            "secId": "s0100",
            "sentence": "Finally, reported differences in response to PCVs between high- and low-income countries, which may reflect differences in pneumococcal carriage rates or particular host factors [40], may limit the generalizability of studies conducted outside the target regions.",
            "startOffset": 53551,
            "title": "Discussion"
        },
        {
            "endOffset": 26633,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All subjects/parents provided written informed consent prior to the conduct of any trial-related procedures and were deemed healthy based on defined eligibility criteria (Table S1).",
            "startOffset": 26452,
            "title": "Study design and participants"
        },
        {
            "endOffset": 28668,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Infants underwent up to 11 clinic visits (primary phase: screening, three vaccination visits 28d apart, each with follow-up visit 7d post-vaccination, plus two follow-up visits 28d and 84d after the final vaccination; booster phase: booster vaccination visit, follow-up visit 28d post-booster) (Fig. 1).",
            "startOffset": 28365,
            "title": "Study design and participants"
        },
        {
            "endOffset": 32623,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Seroprotection thresholds for all pentavalent components except pertussis antigens were predefined.",
            "startOffset": 32524,
            "title": "Assessments"
        },
        {
            "endOffset": 40931,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "There was a substantial booster response for all serotypes in both groups (Table 4).",
            "startOffset": 40847,
            "title": "Toddlers"
        },
        {
            "endOffset": 54096,
            "parents": [],
            "secId": "s0100",
            "sentence": "The study limitations are largely those inherent in any early-phase trial.",
            "startOffset": 54022,
            "title": "Discussion"
        },
        {
            "endOffset": 27868,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The same unblinded nurses prepared and administered all vaccinations in the study but were not involved in any other subject-related procedures or endpoint assessments.",
            "startOffset": 27700,
            "title": "Study design and participants"
        },
        {
            "endOffset": 43663,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0090",
            "sentence": "Prior to the booster vaccination, GMCs were higher in the PCV13 group for serotypes 5, 7F, 14, and 19A and higher in the SIIPL-PCV group for serotype 6B, reflecting differences in the kinetics of immune response between groups for certain serotypes (Table S4 and Fig. 3).",
            "startOffset": 43392,
            "title": "Booster responses"
        },
        {
            "endOffset": 30307,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The Gambia Government/MRC Joint Ethics Committee, Medicines Board of The Gambia Government, and Western Institutional Review Board approved the study protocol, amendments, and informed consent forms.",
            "startOffset": 30108,
            "title": "Study design and participants"
        },
        {
            "endOffset": 31333,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "For infants in the booster phase, AEs were additionally recorded from the booster visit through 28d post-booster.",
            "startOffset": 31220,
            "title": "Assessments"
        },
        {
            "endOffset": 40847,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "The GMCs ranged from 2.30 \u00b5g/mL (95% CI: 1.57\u20133.72) for serotype 5 to15.77 \u00b5g/mL (95% CI: 11.51\u201323.96) for serotype 6B following SIIPL-PCV and from 3.35 \u00b5g/mL (95% CI: 2.46\u20135.35) to 19.16 \u00b5g/mL (95% CI: 14.98\u201330.46) for the same serotypes, respectively, following PCV13.",
            "startOffset": 40577,
            "title": "Toddlers"
        },
        {
            "endOffset": 54796,
            "parents": [],
            "secId": "s0110",
            "sentence": "EC and SL oversaw trial planning and implementation.",
            "startOffset": 54744,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 32350,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 32349,
                    "startOffset": 32342
                },
                "b0090": {
                    "endOffset": 32349,
                    "startOffset": 32342
                },
                "b0095": {
                    "endOffset": 32349,
                    "startOffset": 32342
                }
            },
            "secId": "s0020",
            "sentence": "Seroresponse was defined as a serum IgG level \u22650.35 \u00b5g/mL, a threshold associated with protection against IPD in infants; seroresponse based on the functional assay was defined as a reciprocal OPA titer \u22658 [17\u201319].",
            "startOffset": 32136,
            "title": "Assessments"
        },
        {
            "endOffset": 34335,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The GMC post-booster was also compared with the GMC pre-booster in the toddler and infant cohorts.",
            "startOffset": 34237,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 34496,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 34480,
                    "startOffset": 34476
                }
            },
            "secId": "s0025",
            "sentence": "The CIs around proportions and differences in proportions were calculated using exact methods (exact binomial and unconditional exact method [22], respectively).",
            "startOffset": 34335,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 33075,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The sample size of 100 infants per group provided a \u226590% chance of observing an AE with a 2.3% occurrence rate.",
            "startOffset": 32964,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 42650,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "The GMCs ranged from 1.02 \u00b5g/mL (95% CI: 0.79\u20131.32) for serotype 6A to 4.96 \u00b5g/mL (95% CI: 4.06\u20136.07) for serotype 14 following SIIPL-PCV, and from 1.74 \u00b5g/mL (95% CI: 1.49\u20132.03) for serotype 5 to 5.38 \u00b5g/mL (95% CI: 4.68\u20136.19) for serotype 19F following PCV13.",
            "startOffset": 42389,
            "title": "Primary series responses"
        },
        {
            "endOffset": 37547,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "Four severe TEAEs occurred, including two cases of microcytic anemia in the SIIPL-PCV group deemed unrelated to vaccination.",
            "startOffset": 37423,
            "title": "Toddlers"
        },
        {
            "endOffset": 54873,
            "parents": [],
            "secId": "s0110",
            "sentence": "AOB and MO contributed to and coordinated trial planning and implementation.",
            "startOffset": 54797,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 52591,
            "parents": [],
            "secId": "s0100",
            "sentence": "These observations highlight the importance of assessing not only the primary response, but also antibody persistence and boosting as part of PCV evaluation.",
            "startOffset": 52434,
            "title": "Discussion"
        },
        {
            "endOffset": 54379,
            "parents": [],
            "secId": "s0100",
            "sentence": "Similarly, the study was not sufficiently powered to confidently exclude differences between groups where these were not shown.",
            "startOffset": 54252,
            "title": "Discussion"
        },
        {
            "endOffset": 45142,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0095",
            "sentence": "No meaningful differences were observed in the GMC to any of the three pertussis antigens, tetanus toxoid, diphtheria toxoid, or Hib between groups (Table S6).",
            "startOffset": 44983,
            "title": "Responses to co-administered EPI vaccines"
        },
        {
            "endOffset": 27699,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Once subject eligibility was confirmed, randomization was undertaken by unblinded nurses using the next envelope in sequence.",
            "startOffset": 27574,
            "title": "Study design and participants"
        },
        {
            "endOffset": 28800,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Following each vaccination, trained field workers conducted daily home visits to solicit injection-site and systemic reactogenicity.",
            "startOffset": 28668,
            "title": "Study design and participants"
        },
        {
            "endOffset": 24075,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 24074,
                    "startOffset": 24068
                },
                "b0055": {
                    "endOffset": 24074,
                    "startOffset": 24068
                }
            },
            "secId": "s0005",
            "sentence": "Increased access to safe, efficacious, and affordable PCVs could therefore substantially reduce pneumococcus-related childhood morbidity and mortality [9,11].",
            "startOffset": 23917,
            "title": "Introduction"
        },
        {
            "endOffset": 44620,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0090",
            "sentence": "Comparing GMCs immediately pre-booster with those post-booster showed a robust response for all serotypes following both vaccines (Table S5).",
            "startOffset": 44479,
            "title": "Booster responses"
        },
        {
            "endOffset": 26319,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The last subject completed post-booster follow-up in November 2016.",
            "startOffset": 26252,
            "title": "Study design and participants"
        },
        {
            "endOffset": 41187,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "The GMFRs following PCV13 ranged from 3.35 (95% CI: 2.26\u20135.56) for serotype 14 to 24.17 (95% CI: 17.04\u201338.35) for serotype 19A.",
            "startOffset": 41060,
            "title": "Toddlers"
        },
        {
            "endOffset": 45905,
            "parents": [],
            "secId": "s0100",
            "sentence": "SIIPL-PCV was well-tolerated in all age cohorts, including when co-administered with EPI vaccines in infants.",
            "startOffset": 45796,
            "title": "Discussion"
        },
        {
            "endOffset": 42763,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "The GMC were higher following PCV13 for seven (6A, 6B, 7F, 9V, 19A, 19F, and 23F) of the 10 serotypes (Table 5).",
            "startOffset": 42651,
            "title": "Primary series responses"
        },
        {
            "endOffset": 52214,
            "parents": [],
            "secId": "s0100",
            "sentence": "Only the IgG GMC to serotypes 19A and 19F remained higher in the PCV13 group post-booster.",
            "startOffset": 52124,
            "title": "Discussion"
        },
        {
            "endOffset": 50922,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 50921,
                    "startOffset": 50914
                },
                "b0210": {
                    "endOffset": 50921,
                    "startOffset": 50914
                },
                "b0215": {
                    "endOffset": 50921,
                    "startOffset": 50914
                }
            },
            "secId": "s0100",
            "sentence": "Data have suggested that OPA titers may ultimately correlate better with estimates of vaccine effectiveness than IgG concentrations, and high vaccine effectiveness has been demonstrated against disease endpoints despite generally lower IgG GMC than reported here [41\u201343].",
            "startOffset": 50651,
            "title": "Discussion"
        },
        {
            "endOffset": 53550,
            "parents": [],
            "secId": "s0100",
            "sentence": "The high per protocol follow-up and completion rates lend confidence in the results and ensured the maximum value of the study design was realized.",
            "startOffset": 53403,
            "title": "Discussion"
        },
        {
            "endOffset": 45796,
            "parents": [],
            "secId": "s0100",
            "sentence": "The study was completed as planned, with age de-escalation from adults to toddlers and from toddlers to infants dependent on an independent review of safety data from the preceding cohort.",
            "startOffset": 45608,
            "title": "Discussion"
        },
        {
            "endOffset": 46878,
            "parents": [],
            "secId": "s0100",
            "sentence": "The responses to other serotypes were comparable.",
            "startOffset": 46829,
            "title": "Discussion"
        },
        {
            "endOffset": 26760,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "An unblinded data and safety monitoring board reviewed safety data before vaccination of the next descending age cohort began.",
            "startOffset": 26634,
            "title": "Study design and participants"
        },
        {
            "endOffset": 35061,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Since >80% of HepB antibody concentrations were reported as >1000 mIU/mL, the percent exceeding the seroresponse threshold was calculated but GMCs were not.",
            "startOffset": 34905,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 42388,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "The point estimates for the serotype-specific IgG GMCs after the primary series were above 1 \u00b5g/mL for all serotypes following both vaccines.",
            "startOffset": 42247,
            "title": "Primary series responses"
        },
        {
            "endOffset": 31083,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Biochemical and hematological laboratory examinations were undertaken at screening in all cohorts and 7d post-vaccination in adults and toddlers.",
            "startOffset": 30938,
            "title": "Assessments"
        },
        {
            "endOffset": 37261,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "The most common TEAEs in toddlers were infections (44.6% SIIPL-PCV, 50.0% PCV13), particularly upper respiratory tract infections (URTIs), and gastrointestinal disorders (16.1% SIIPL-PCV, 10.7% PCV13), including diarrhea (Table S2).",
            "startOffset": 37029,
            "title": "Toddlers"
        },
        {
            "endOffset": 29485,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 29484,
                    "startOffset": 29477
                },
                "b0070": {
                    "endOffset": 29484,
                    "startOffset": 29477
                }
            },
            "secId": "s0015",
            "sentence": "PPSV23 and PCV13 composition has been described previously [13,14].",
            "startOffset": 29418,
            "title": "Study design and participants"
        },
        {
            "endOffset": 55172,
            "parents": [],
            "secId": "s0110",
            "sentence": "All authors provided input into the manuscript and approved the final manuscript.",
            "startOffset": 55091,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 36269,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0045",
            "sentence": "No SAEs occurred in adults.",
            "startOffset": 36242,
            "title": "Adults"
        },
        {
            "endOffset": 48095,
            "parents": [],
            "secId": "s0100",
            "sentence": "For three serotypes (5, 9V, and 19A) the magnitude of the booster response was greater following PCV13 than SIIPL-PCV although this in part reflected baseline GMCs, which tended to be higher in the SIIPL-PCV group.",
            "startOffset": 47881,
            "title": "Discussion"
        },
        {
            "endOffset": 54743,
            "parents": [],
            "secId": "s0110",
            "sentence": "SL, MRA, JF and EC contributed to trial design.",
            "startOffset": 54696,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 34747,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Subjects who did not complete the study contributed to analyses as available.",
            "startOffset": 34670,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 51778,
            "parents": [],
            "secId": "s0100",
            "sentence": "The lack of booster response to serotype 5 reflected, at least in part, the relatively higher IgG GMC to this serotype in the SIIPL-PCV group following the primary immunization series, as the post-booster IgG GMCs for this serotype were comparable between the SIIPL-PCV and the PCV13 groups.",
            "startOffset": 51487,
            "title": "Discussion"
        },
        {
            "endOffset": 30551,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Infants receiving a booster were bled pre-booster and 28d post-booster.",
            "startOffset": 30480,
            "title": "Assessments"
        },
        {
            "endOffset": 33436,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The same sample size provided >99% power to detect a two-fold difference in geometric mean concentration (GMC) between groups and >80% power to detect a 10% lower seroresponse rate following SIIPL-PCV assuming a 98% seroresponse following PCV13.",
            "startOffset": 33191,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 39236,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "The only severe TEAEs reported in more than one infant were two bronchiolitis events in the SIIPL-PCV infant group.",
            "startOffset": 39121,
            "title": "Infants"
        },
        {
            "endOffset": 45500,
            "parents": [],
            "secId": "s0100",
            "sentence": "This phase 1/2 trial provides safety, tolerability, and immunogenicity data on SIIPL-PCV\u2014a novel 10-valent PCV that contains serotypes chosen to maximize coverage against pneumococcal disease in LMICs.",
            "startOffset": 45299,
            "title": "Discussion"
        },
        {
            "endOffset": 44120,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0090",
            "sentence": "Comparing GMCs post-booster with GMCs post-primary immunization, the GMC ratios ranged from 1.13 (95% CI: 0.87\u20131.44) for serotype 5 to 9.03 (95% CI: 5.92\u201313.79) for serotype 6A following SIIPL-PCV and from 1.46 (95% CI: 1.12\u20131.89) for serotype 9V to 7.75 (95% CI: 5.49\u201310.94) for serotype 6A following PCV13.",
            "startOffset": 43812,
            "title": "Booster responses"
        },
        {
            "endOffset": 45607,
            "parents": [],
            "secId": "s0100",
            "sentence": "It also provides preliminary data to support the co-administration of SIIPL-PCV with primary EPI vaccines.",
            "startOffset": 45501,
            "title": "Discussion"
        },
        {
            "endOffset": 23642,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 23641,
                    "startOffset": 23636
                },
                "b0015": {
                    "endOffset": 23641,
                    "startOffset": 23636
                }
            },
            "secId": "s0005",
            "sentence": "Despite this, the burden of vaccine-preventable pneumococcal pneumonia and IPD remains high in many low-resource settings related to delayed PCV introduction and low coverage [2,3].",
            "startOffset": 23461,
            "title": "Introduction"
        },
        {
            "endOffset": 30479,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Blood samples were collected pre-vaccination and 28d post-vaccination for adults and toddlers, and pre-vaccination and 28d post third vaccination for infants.",
            "startOffset": 30321,
            "title": "Assessments"
        },
        {
            "endOffset": 52856,
            "parents": [],
            "secId": "s0100",
            "sentence": "The integrated phase 1/2 age de-escalation design minimized logistical delay and ensured robust safety and immunogenicity data were generated in six-week-old infants to guide further vaccine development in a timely manner.",
            "startOffset": 52634,
            "title": "Discussion"
        },
        {
            "endOffset": 50011,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 50010,
                    "startOffset": 50003
                },
                "b0105": {
                    "endOffset": 50010,
                    "startOffset": 50003
                }
            },
            "secId": "s0100",
            "sentence": "The point estimate for the difference in the seroresponse rates following SIIPL-PCV compared to PCV13 was below the \u221210% non-inferiority margin used in previous PCV licensure trials for serotype 6A alone [20,21].",
            "startOffset": 49799,
            "title": "Discussion"
        },
        {
            "endOffset": 37739,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "Two severe SAEs occurred\u2014one (gastroenteritis) in the SIIPL-PCV group and one (pneumonia) in the PCV13 group, both of which were deemed unrelated to vaccination and resolved without sequelae.",
            "startOffset": 37548,
            "title": "Toddlers"
        },
        {
            "endOffset": 55275,
            "parents": [],
            "secId": "s0115",
            "sentence": "This manuscript is based on research funded through PATH by the Bill & Melinda Gates Foundation.",
            "startOffset": 55179,
            "title": "Funding"
        },
        {
            "endOffset": 26058,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This was a phase 1/2, parallel-group, randomized, double-blind, age de-escalation trial conducted by MRC Unit The Gambia\u2014part of the London School of Hygiene and Tropical Medicine\u2014in clinical trial facilities in the peri-urban Western region of The Gambia.",
            "startOffset": 25802,
            "title": "Study design and participants"
        },
        {
            "endOffset": 39483,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0060",
            "sentence": "No noteworthy trends from baseline were observed in vital signs, physical examination findings or post-vaccination laboratory examinations.",
            "startOffset": 39344,
            "title": "Additional safety assessments"
        },
        {
            "endOffset": 48521,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 48520,
                    "startOffset": 48513
                },
                "b0185": {
                    "endOffset": 48520,
                    "startOffset": 48513
                }
            },
            "secId": "s0100",
            "sentence": "Nasopharyngeal carriage of pneumococci in this age-group in The Gambia is in the region of 90%, including persistent vaccine-type carriage (e.g., 7F, 19F, and 23F) despite high PCV13 coverage [34,37].",
            "startOffset": 48321,
            "title": "Discussion"
        },
        {
            "endOffset": 48729,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 48728,
                    "startOffset": 48721
                },
                "b0195": {
                    "endOffset": 48728,
                    "startOffset": 48721
                }
            },
            "secId": "s0100",
            "sentence": "Few studies have examined the interchangeability of primary and booster PCV [38,39].",
            "startOffset": 48645,
            "title": "Discussion"
        },
        {
            "endOffset": 36951,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0050",
            "sentence": "Systemic reactogenicity was mild to moderate, except for three events of severe (>39 \u00b0C\u201340 \u00b0C) fever, two of which occurred following PCV13 and one following SIIPL-PCV.",
            "startOffset": 36783,
            "title": "Toddlers"
        },
        {
            "endOffset": 49798,
            "parents": [],
            "secId": "s0100",
            "sentence": "The seroresponse rates following a three-dose primary series of SIIPL-PCV were above 90% for all except two serotypes.",
            "startOffset": 49680,
            "title": "Discussion"
        },
        {
            "endOffset": 33610,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 33609,
                    "startOffset": 33602
                },
                "b0105": {
                    "endOffset": 33609,
                    "startOffset": 33602
                }
            },
            "secId": "s0025",
            "sentence": "Although not tested in this study, these criteria are relevant because they reflect the margins of immunologic non-inferiority used in previous PCV licensure trials [20,21].",
            "startOffset": 33437,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 35217,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "All cohorts met recruitment targets and all adults (Fig. 2A) and toddlers (Fig. 2B) completed the study per protocol.",
            "startOffset": 35100,
            "title": "Disposition and demographics"
        },
        {
            "endOffset": 38030,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "One episode of severe cutaneous rash and one episode of severe irritability were also reported in the SIIPL-PCV group during the primary phase of the trial.",
            "startOffset": 37874,
            "title": "Infants"
        },
        {
            "endOffset": 39310,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "No concerning trends were observed in the frequency of any grade of TEAE.",
            "startOffset": 39237,
            "title": "Infants"
        },
        {
            "endOffset": 35838,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0045",
            "sentence": "All solicited injection-site and systemic reactogenicity in adults was mild and resolved within 24\u201348 h, with no meaningful differences between treatment groups (data not shown).",
            "startOffset": 35660,
            "title": "Adults"
        },
        {
            "endOffset": 53330,
            "parents": [],
            "secId": "s0100",
            "sentence": "The inclusion of an additional dose of the vaccine given between 10 and 14 months of age, and blood sample collected pre-booster, allowed both antibody persistence and booster response to be assessed.",
            "startOffset": 53130,
            "title": "Discussion"
        },
        {
            "endOffset": 25138,
            "parents": [],
            "secId": "s0005",
            "sentence": "This phase 1/2, age de-escalation trial evaluated the safety, tolerability (primary objectives), and immunogenicity (secondary objectives) of SIIPL-PCV compared to the licensed 23-valent pneumococcal polysaccharide vaccine (Pneumovax23\u00ae, Merck\u00ae [PPSV23]) in adults and compared to the 13-valent PCV (Prevenar13\u00ae, Pfizer\u00ae [PCV13]) in toddlers and infants.",
            "startOffset": 24784,
            "title": "Introduction"
        },
        {
            "endOffset": 38798,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "Ten infants had a study vaccine-related TEAE (two in the SIIPL-PCV group and eight in the PCV13 group)\u2014primarily persistent injection-site swelling (two and seven infants, respectively).",
            "startOffset": 38612,
            "title": "Infants"
        },
        {
            "endOffset": 23194,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 23193,
                    "startOffset": 23188
                },
                "b0015": {
                    "endOffset": 23193,
                    "startOffset": 23188
                }
            },
            "secId": "s0005",
            "sentence": "Invasive pneumococcal disease (IPD), including sepsis and meningitis, also results in high childhood morbidity and mortality, particularly in low-resource settings [2,3].",
            "startOffset": 23024,
            "title": "Introduction"
        },
        {
            "endOffset": 47880,
            "parents": [],
            "secId": "s0100",
            "sentence": "The post-booster vaccination GMCs were comparable between groups.",
            "startOffset": 47815,
            "title": "Discussion"
        },
        {
            "endOffset": 33190,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "If no AE occurred, the upper limit of the one-sided 95% confidence interval (CI) for the occurrence rate was 3.0%.",
            "startOffset": 33076,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 42247,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "These rates were lower than the responses to the same serotypes induced by PCV13 (6A: \u221212.0% [95% CI: \u221221.9\u20132.0]; 6B: \u22127.9% [95% CI: \u221215.8\u20130.5]).",
            "startOffset": 42102,
            "title": "Primary series responses"
        },
        {
            "endOffset": 24784,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore, if SIIPL-PCV is found to be safe and immunogenic, it will be provided at a considerably lower price than currently licensed PCVs.",
            "startOffset": 24644,
            "title": "Introduction"
        },
        {
            "endOffset": 46700,
            "parents": [],
            "secId": "s0100",
            "sentence": "In the adult cohort, the IgG GMCs and OPA GMTs were consistently high four weeks after the administration of a single dose of either SIIPL-PCV or PPSV23.",
            "startOffset": 46547,
            "title": "Discussion"
        },
        {
            "endOffset": 52633,
            "parents": [],
            "secId": "s0100",
            "sentence": "The study has several important strengths.",
            "startOffset": 52591,
            "title": "Discussion"
        },
        {
            "endOffset": 44883,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0095",
            "sentence": "All infants had IgG concentrations above the defined seroprotective thresholds for tetanus, diphtheria, and HepB whether the three routine doses of DTwP-HepB-Hib vaccine were co-administered with SIIPL-PCV or PCV13.",
            "startOffset": 44668,
            "title": "Responses to co-administered EPI vaccines"
        },
        {
            "endOffset": 55022,
            "parents": [],
            "secId": "s0110",
            "sentence": "DHW analyzed the data.",
            "startOffset": 55000,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 47310,
            "parents": [],
            "refoffsets": {
                "b0150": {
                    "endOffset": 47309,
                    "startOffset": 47302
                },
                "b0155": {
                    "endOffset": 47309,
                    "startOffset": 47302
                },
                "b0160": {
                    "endOffset": 47309,
                    "startOffset": 47302
                }
            },
            "secId": "s0100",
            "sentence": "Data on the protection conferred by PPSV23 in low-income settings are also limited [30\u201332].",
            "startOffset": 47219,
            "title": "Discussion"
        },
        {
            "endOffset": 36091,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0045",
            "sentence": "Four (23.5%) and 10 (58.8%) adults in the SIIPL-PCV and PPSV23 groups, respectively, had at least one TEAE, most commonly a gastrointestinal disorder (11.8% and 35.3% of adults in each group respectively), all of which were mild or moderate in severity.",
            "startOffset": 35838,
            "title": "Adults"
        },
        {
            "endOffset": 46828,
            "parents": [],
            "secId": "s0100",
            "sentence": "The responses to serotype 6A and 6B were higher following SIIPL-PCV and the response to serotype 1 was higher following PPSV23.",
            "startOffset": 46701,
            "title": "Discussion"
        },
        {
            "endOffset": 23023,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 23022,
                    "startOffset": 23019
                }
            },
            "secId": "s0005",
            "sentence": "Streptococcus pneumoniae is the leading cause of severe pneumonia worldwide, a condition which, in 2015, caused nearly one million deaths in children under five years old [1].",
            "startOffset": 22848,
            "title": "Introduction"
        },
        {
            "endOffset": 51486,
            "parents": [],
            "secId": "s0100",
            "sentence": "Comparing GMCs post-booster vaccination with the GMCs post-primary series, there was a booster response to all serotypes except serotype 5 following SIIPL-PCV.",
            "startOffset": 51327,
            "title": "Discussion"
        },
        {
            "endOffset": 31586,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Vaccine-relatedness of systemic reactogenicity and treatment-emergent AEs (TEAEs) was evaluated by site clinicians.",
            "startOffset": 31471,
            "title": "Assessments"
        },
        {
            "endOffset": 49680,
            "parents": [],
            "secId": "s0100",
            "sentence": "The guidance specifies that post-primary non-inferiority to a licensed PCV must be demonstrated, based on either seroresponse rates or IgG GMCs.",
            "startOffset": 49536,
            "title": "Discussion"
        },
        {
            "endOffset": 27032,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "To evaluate immune persistence and the response to booster vaccination post-priming, the protocol was amended to include a matching dose of either SIIPL-PCV or PCV13 to be given at \u226510 months old to booster-eligible infant subjects whose parent provided separate consent.",
            "startOffset": 26761,
            "title": "Study design and participants"
        },
        {
            "endOffset": 40189,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0070",
            "sentence": "The responses to the remaining six serotypes were comparable between groups (Table S3).",
            "startOffset": 40102,
            "title": "Adults"
        },
        {
            "endOffset": 24427,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 24426,
                    "startOffset": 24422
                }
            },
            "secId": "s0005",
            "sentence": "Thus, the vaccine offers comparable serotype coverage to licensed PCVs in these settings [12].",
            "startOffset": 24333,
            "title": "Introduction"
        },
        {
            "endOffset": 24332,
            "parents": [],
            "secId": "s0005",
            "sentence": "The 10-valent candidate PCV developed by Serum Institute of India Pvt. Ltd. (SIIPL), SIIPL-PCV, incorporates the most prevalent IPD-causing serotypes prior to PCV introduction in Africa, Asia, and Latin America (1, 5, 6A, 6B, 7F, 9V, 14, 19A, 19F, and 23F).",
            "startOffset": 24075,
            "title": "Introduction"
        },
        {
            "endOffset": 29383,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A single 0.5 mL dose of SIIPL-PCV contains 2 \u03bcg of polysaccharide for serotypes 1, 5, 9V, 14, 19A, 19F, 23F, 7F, and 6A, and 4 \u03bcg for serotype 6B, each individually conjugated to the diphtheria toxoid-derived recombinant Cross-Reactive-Material 197 (CRM197), with 0.125 mg per dose of aluminum as aluminum phosphate.",
            "startOffset": 29067,
            "title": "Study design and participants"
        },
        {
            "endOffset": 34107,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Treatment groups were compared using GMC ratio, GMT ratio or GMFR ratio (SIIPL-PCV/comparator), and difference in seroresponse rates (SIIPL-PCV minus comparator).",
            "startOffset": 33945,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 38373,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "While the rates of injection-site and systemic reactogenicity after each of the three vaccinations in infants were somewhat variable, no trends were apparent following either SIIPL-PCV or PCV13 (Table 2).",
            "startOffset": 38169,
            "title": "Infants"
        },
        {
            "endOffset": 47814,
            "parents": [],
            "secId": "s0100",
            "sentence": "In PCV13-primed toddlers, a substantial booster response to all serotypes was observed in both treatment groups.",
            "startOffset": 47702,
            "title": "Discussion"
        },
        {
            "endOffset": 31470,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "AEs were categorized using MedDRA version 17.1 and severity graded from one (mild) to five (resulted in death) per protocol definitions.",
            "startOffset": 31334,
            "title": "Assessments"
        },
        {
            "endOffset": 33944,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Immunogenicity endpoints were GMCs or geometric mean titers (GMTs); geometric mean fold-rise (GMFR), where fold-rise was calculated as a subject\u2019s later measurement divided by their earlier measurement; and seroresponse rates.",
            "startOffset": 33718,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 40576,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "In PCV13-primed toddlers, the serotype-specific IgG GMCs after the booster dose of either SIIPL-PCV or PCV13 were comparable (Table 4).",
            "startOffset": 40441,
            "title": "Toddlers"
        },
        {
            "endOffset": 47539,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 47538,
                    "startOffset": 47531
                },
                "b0170": {
                    "endOffset": 47538,
                    "startOffset": 47531
                },
                "b0175": {
                    "endOffset": 47538,
                    "startOffset": 47531
                },
                "b0180": {
                    "endOffset": 47538,
                    "startOffset": 47531
                }
            },
            "secId": "s0100",
            "sentence": "Furthermore, nasopharyngeal pneumococcal carriage in The Gambia remains \u226550% in adults of the age recruited to this trial and may impact not only natural, but also vaccine-induced serotype-specific pneumococcal immunity [33\u201336].",
            "startOffset": 47311,
            "title": "Discussion"
        },
        {
            "endOffset": 54933,
            "parents": [],
            "secId": "s0110",
            "sentence": "AOB, MO, AU, MBH, IA and DG contributed to data collection.",
            "startOffset": 54874,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 38879,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "Six infants in the SIIPL-PCV group and two infants in the PCV13 group had an SAE.",
            "startOffset": 38798,
            "title": "Infants"
        },
        {
            "endOffset": 41590,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                }
            ],
            "secId": "s0075",
            "sentence": "GMT ratios ranged from 0.78 (95% CI: 0.32\u20131.69) for serotype 9V to 3.21 (95% CI: 1.36\u20137.44) for serotype 14.",
            "startOffset": 41482,
            "title": "Toddlers"
        },
        {
            "endOffset": 26251,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Sequential cohorts of 34 PCV-naive adults (18\u201340 years old), 112 PCV13-vaccinated toddlers (12\u201315 months old), and 200 PCV-naive infants (6\u20138 weeks old) were enrolled starting in January 2015.",
            "startOffset": 26059,
            "title": "Study design and participants"
        },
        {
            "endOffset": 27460,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Randomization sequences were generated using permuted blocks with randomly selected block sizes by an independent biostatistician implementing a validated SAS\u00ae macro.",
            "startOffset": 27294,
            "title": "Study design and participants"
        },
        {
            "endOffset": 32734,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "No hypothesis testing was planned.",
            "startOffset": 32700,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 42101,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0085",
            "sentence": "The seroresponse rate was 79.0% (95% CI: 69.7\u201386.5) against serotype 6A and was 89.0% (95% CI: 81.2\u201394.4) against serotype 6B following SIIPL-PCV.",
            "startOffset": 41955,
            "title": "Primary series responses"
        },
        {
            "endOffset": 54251,
            "parents": [],
            "secId": "s0100",
            "sentence": "Where differences do exist, they should be interpreted with caution given there was no accounting for multiplicity.",
            "startOffset": 54136,
            "title": "Discussion"
        },
        {
            "endOffset": 27293,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Adults were randomized 1:1 (stratified by sex) to receive a single dose of either SIIPL-PCV or PPSV23, while toddlers and infants were randomized 1:1 to receive either SIIPL-PCV or PCV13 (single booster dose for toddlers, three-dose primary series for infants).",
            "startOffset": 27032,
            "title": "Study design and participants"
        },
        {
            "endOffset": 29955,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "DTwP-HepB-Hib (SIIPL), bivalent oral poliovirus vaccine (SIIPL), and oral rotavirus vaccine (Rotateq\u00ae, MSD Vaccines) were co-administered with all primary doses, and inactivated poliovirus vaccine (SIIPL) was co-administered with the third dose according to The Gambian EPI schedule.",
            "startOffset": 29672,
            "title": "Study design and participants"
        },
        {
            "endOffset": 34670,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 34669,
                    "startOffset": 34662
                },
                "b0120": {
                    "endOffset": 34669,
                    "startOffset": 34662
                }
            },
            "secId": "s0025",
            "sentence": "The CIs around GMCs, etc. were constructed using t-tests assuming log-normality or, where this assumption was not met, from bootstrap resampling (10,000 replicates) [23,24].",
            "startOffset": 34497,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 45288,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0065",
                    "title": "Immunogenicity results"
                },
                {
                    "id": "s0080",
                    "title": "Infants"
                }
            ],
            "secId": "s0095",
            "sentence": "As such, nothing was observed to indicate differential interference with responses to pentavalent vaccine components between SIIPL-PCV and PCV13.",
            "startOffset": 45143,
            "title": "Responses to co-administered EPI vaccines"
        },
        {
            "endOffset": 49535,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 49534,
                    "startOffset": 49530
                }
            },
            "secId": "s0100",
            "sentence": "Data from the infant cohort were intended to inform the decision to advance to a pivotal phase 3 trial designed to demonstrate that SIIPL-PCV meets the product specifications required of a licensed and prequalified PCV as detailed in WHO guidance [40].",
            "startOffset": 49283,
            "title": "Discussion"
        },
        {
            "endOffset": 25315,
            "parents": [],
            "secId": "s0005",
            "sentence": "Adults and toddlers received a single dose of either SIIPL-PCV or comparator vaccine while infants received three-doses of either SIIPL-PCV or PCV13 at 6, 10, and 14 weeks old.",
            "startOffset": 25139,
            "title": "Introduction"
        },
        {
            "endOffset": 50472,
            "parents": [],
            "secId": "s0100",
            "sentence": "Furthermore, the percentage of subjects with functional OPA antibodies (titer \u22658) was above 93%, and was similar between the two groups, for all 10 serotypes.",
            "startOffset": 50314,
            "title": "Discussion"
        },
        {
            "endOffset": 39121,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Safety"
                }
            ],
            "secId": "s0055",
            "sentence": "All SAEs were deemed unrelated to vaccination and resolved without sequelae.",
            "startOffset": 39045,
            "title": "Infants"
        }
    ],
    "docId": "S0264410X1931148X",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "Ed.Clarke@lshtm.ac.uk",
                "first": "Ed",
                "initial": "E.",
                "last": "Clarke"
            },
            {
                "email": null,
                "first": "Adedapo O.",
                "initial": "A.O.",
                "last": "Bashorun"
            },
            {
                "email": null,
                "first": "Michael",
                "initial": "M.",
                "last": "Okoye"
            },
            {
                "email": null,
                "first": "Ama",
                "initial": "A.",
                "last": "Umesi"
            },
            {
                "email": null,
                "first": "Mariama",
                "initial": "M.",
                "last": "Badjie Hydara"
            },
            {
                "email": null,
                "first": "Ikechukwu",
                "initial": "I.",
                "last": "Adigweme"
            },
            {
                "email": null,
                "first": "Rajeev",
                "initial": "R.",
                "last": "Dhere"
            },
            {
                "email": null,
                "first": "Vistasp",
                "initial": "V.",
                "last": "Sethna"
            },
            {
                "email": null,
                "first": "Beate",
                "initial": "B.",
                "last": "Kampmann"
            },
            {
                "email": null,
                "first": "David",
                "initial": "D.",
                "last": "Goldblatt"
            },
            {
                "email": null,
                "first": "Andi",
                "initial": "A.",
                "last": "Tate"
            },
            {
                "email": null,
                "first": "Debra H.",
                "initial": "D.H.",
                "last": "Weiner"
            },
            {
                "email": null,
                "first": "Jorge",
                "initial": "J.",
                "last": "Flores"
            },
            {
                "email": null,
                "first": "Mark R.",
                "initial": "M.R.",
                "last": "Alderson"
            },
            {
                "email": null,
                "first": "Steve",
                "initial": "S.",
                "last": "Lamola"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.08.072",
        "firstpage": "399",
        "issn": "0264410X",
        "keywords": [
            "Adult",
            "Immunogenicity",
            "Infant",
            "Phase 1/2",
            "Pneumococcal conjugate vaccine",
            "Reactogenicity",
            "Safety",
            "Toddler",
            "Tolerability"
        ],
        "lastpage": "410",
        "openaccess": "Full",
        "pub_year": 2020,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia\u2014Results of a phase 1/2 randomized, double-blinded, controlled trial"
    }
}